Motif 352 (n=63)
Position-wise Probabilities
Download
uniprot | genes | site | source | protein | function |
---|---|---|---|---|---|
A6NDE4 | RBMY1B | S176 | ochoa | RNA-binding motif protein, Y chromosome, family 1 member B | RNA-binding protein which may be involved in spermatogenesis. Required for sperm development, possibly by participating in pre-mRNA splicing in the testis. |
A6NEQ0 | RBMY1E | S176 | ochoa | RNA-binding motif protein, Y chromosome, family 1 member E | RNA-binding protein which may be involved in spermatogenesis. Required for sperm development, possibly by participating in pre-mRNA splicing in the testis. |
A6QL63 | ABTB3 | S65 | ochoa | Ankyrin repeat- and BTB/POZ domain-containing protein 3 (BTB/POZ domain-containing protein 11) | None |
O14640 | DVL1 | S676 | ochoa | Segment polarity protein dishevelled homolog DVL-1 (Dishevelled-1) (DSH homolog 1) | Participates in Wnt signaling by binding to the cytoplasmic C-terminus of frizzled family members and transducing the Wnt signal to down-stream effectors. Plays a role both in canonical and non-canonical Wnt signaling. Plays a role in the signal transduction pathways mediated by multiple Wnt genes. Required for LEF1 activation upon WNT1 and WNT3A signaling. DVL1 and PAK1 form a ternary complex with MUSK which is important for MUSK-dependent regulation of AChR clustering during the formation of the neuromuscular junction (NMJ). |
O14641 | DVL2 | S717 | ochoa | Segment polarity protein dishevelled homolog DVL-2 (Dishevelled-2) (DSH homolog 2) | Plays a role in the signal transduction pathways mediated by multiple Wnt genes (PubMed:24616100). Participates both in canonical and non-canonical Wnt signaling by binding to the cytoplasmic C-terminus of frizzled family members and transducing the Wnt signal to down-stream effectors. Promotes internalization and degradation of frizzled proteins upon Wnt signaling. {ECO:0000250|UniProtKB:Q60838, ECO:0000269|PubMed:19252499, ECO:0000269|PubMed:24616100}. |
O14686 | KMT2D | S2945 | ochoa | Histone-lysine N-methyltransferase 2D (Lysine N-methyltransferase 2D) (EC 2.1.1.364) (ALL1-related protein) (Myeloid/lymphoid or mixed-lineage leukemia protein 2) | Histone methyltransferase that catalyzes methyl group transfer from S-adenosyl-L-methionine to the epsilon-amino group of 'Lys-4' of histone H3 (H3K4) (PubMed:25561738). Part of chromatin remodeling machinery predominantly forms H3K4me1 methylation marks at active chromatin sites where transcription and DNA repair take place (PubMed:17500065, PubMed:25561738). Acts as a coactivator for estrogen receptor by being recruited by ESR1, thereby activating transcription (PubMed:16603732). {ECO:0000269|PubMed:16603732, ECO:0000269|PubMed:17500065, ECO:0000269|PubMed:25561738}. |
O60493 | SNX3 | S72 | ochoa | Sorting nexin-3 (Protein SDP3) | Phosphoinositide-binding protein required for multivesicular body formation. Specifically binds phosphatidylinositol 3-phosphate (PtdIns(P3)). Can also bind phosphatidylinositol 4-phosphate (PtdIns(P4)), phosphatidylinositol 5-phosphate (PtdIns(P5)) and phosphatidylinositol 3,5-biphosphate (PtdIns(3,5)P2) (By similarity). Plays a role in protein transport between cellular compartments. Together with RAB7A facilitates endosome membrane association of the retromer cargo-selective subcomplex (CSC/VPS). May in part act as component of the SNX3-retromer complex which mediates the retrograde endosome-to-TGN transport of WLS distinct from the SNX-BAR retromer pathway (PubMed:21725319, PubMed:24344282, PubMed:30213940). Promotes stability and cell surface expression of epithelial sodium channel (ENAC) subunits SCNN1A and SCNN1G (By similarity). Not involved in EGFR degradation. Involved in the regulation of phagocytosis in dendritic cells possibly by regulating EEA1 recruitment to the nascent phagosomes (PubMed:23237080). Involved in iron homeostasis through regulation of endocytic recycling of the transferrin receptor TFRC presumably by delivering the transferrin:transferrin receptor complex to recycling endosomes; the function may involve the CSC retromer subcomplex (By similarity). In the case of Salmonella enterica infection plays arole in maturation of the Salmonella-containing vacuole (SCV) and promotes recruitment of LAMP1 to SCVs (PubMed:20482551). {ECO:0000250|UniProtKB:O70492, ECO:0000269|PubMed:11433298, ECO:0000269|PubMed:18767904, ECO:0000269|PubMed:21725319, ECO:0000269|PubMed:23237080, ECO:0000269|PubMed:24344282, ECO:0000305|PubMed:21725319}. |
O76090 | BEST1 | S358 | psp | Bestrophin-1 (TU15B) (Vitelliform macular dystrophy protein 2) | Ligand-gated anion channel that allows the movement of anions across cell membranes when activated by calcium (Ca2+) (PubMed:11904445, PubMed:12907679, PubMed:18179881, PubMed:18400985, PubMed:19853238, PubMed:21330666, PubMed:26200502, PubMed:26720466, PubMed:35789156). Allows the movement of chloride and hydrogencarbonate (PubMed:11904445, PubMed:12907679, PubMed:18179881, PubMed:18400985, PubMed:19853238, PubMed:21330666, PubMed:26200502, PubMed:26720466, PubMed:35789156). Found in a partially open conformation leading to significantly smaller chloride movement (PubMed:35789156). Upon F2R/PAR-1 activation, the sequestered calcium is released into the cytosol of astrocytes, leading to the (Ca2+)-dependent release of L-glutamate into the synaptic cleft that targets the neuronal postsynaptic GRIN2A/NMDAR receptor resulting in the synaptic plasticity regulation (By similarity). Upon activation of the norepinephrine-alpha-1 adrenergic receptor signaling pathway, transports as well D-serine than L-glutamate in a (Ca2+)-dependent manner, leading to activation of adjacent NMDAR receptors and therefore regulates the heterosynaptic long-term depression and metaplasticity during initial memory acquisition (By similarity). Releases the 4-aminobutanoate neurotransmitter in a (Ca2+)-dependent manner, and participates in its tonic release from cerebellar glial cells (By similarity). {ECO:0000250|UniProtKB:O88870, ECO:0000269|PubMed:11904445, ECO:0000269|PubMed:12907679, ECO:0000269|PubMed:18179881, ECO:0000269|PubMed:18400985, ECO:0000269|PubMed:19853238, ECO:0000269|PubMed:21330666, ECO:0000269|PubMed:26200502, ECO:0000269|PubMed:26720466, ECO:0000269|PubMed:35789156}. |
P07996 | THBS1 | S627 | ochoa | Thrombospondin-1 (Glycoprotein G) | Adhesive glycoprotein that mediates cell-to-cell and cell-to-matrix interactions (PubMed:15014436, PubMed:18285447, PubMed:2430973, PubMed:6489349). Multifunctional, involved in inflammation, angiogenesis, wound healing, reactive oxygen species (ROS) signaling, nitrous oxide (NO) signaling, apoptosis, senescence, aging, cellular self-renewal, stemness, and cardiovascular and metabolic homeostasis (PubMed:10613822, PubMed:11134179, PubMed:1371676, PubMed:14568985, PubMed:24511121, PubMed:29042481, PubMed:32679764). Negatively modulates dendritic cell activation and cytokine release, as part of an autocrine feedback loop, contributing to the resolution of inflammation and immune homeostasis (PubMed:14568985). Ligand for receptor CD47 (PubMed:19004835, PubMed:8550562). Modulates nitrous oxide (NO) signaling via CD47, hence playing a role as a pressor agent, supporting blood pressure (By similarity). Plays a role in endothelial cell senescence, acting via CD47, by increasing the abundance and activation of NADPH oxidase NOX1, and so generating excess ROS (PubMed:29042481). Inhibits stem cell self-renewal, acting via CD47 signaling, probably by regulation of the stem cell transcription factors POU5F1/OCT4, SOX2, MYC/c-Myc and KLF4 (By similarity). Negatively modulates wound healing, acting via CD47 (By similarity). Ligand for receptor CD36 (PubMed:10613822, PubMed:11134179, PubMed:1371676). Involved in inducing apoptosis in podocytes in response to elevated free fatty acids, acting via CD36 (By similarity). Plays a role in suppressing angiogenesis, acting, depending on context, via CD36 or CD47 (PubMed:10613822, PubMed:11134179, PubMed:1371676, PubMed:32679764). Promotes cellular senescence in a TP53-CDKN1A-RB1 signaling-dependent manner (PubMed:29042481). Ligand for immunoglobulin-like cell surface receptor SIRPA (PubMed:24511121). Involved in ROS signaling in non-phagocytic cells, stimulating NADPH oxidase-derived ROS production, acting via interaction with SIRPA (PubMed:24511121). Plays a role in metabolic dysfunction in diet-induced obesity, perhaps acting by exacerbating adipose inflammatory activity; its effects may be mediated, at least in part, through enhanced adipocyte proliferation (By similarity). Plays a role in ER stress response, via its interaction with the activating transcription factor 6 alpha (ATF6) which produces adaptive ER stress response factors (By similarity). May be involved in age-related conditions, including metabolic dysregulation, during normal aging (PubMed:29042481, PubMed:32679764). {ECO:0000250|UniProtKB:P35441, ECO:0000269|PubMed:10613822, ECO:0000269|PubMed:11134179, ECO:0000269|PubMed:1371676, ECO:0000269|PubMed:14568985, ECO:0000269|PubMed:15014436, ECO:0000269|PubMed:18285447, ECO:0000269|PubMed:19004835, ECO:0000269|PubMed:2430973, ECO:0000269|PubMed:24511121, ECO:0000269|PubMed:29042481, ECO:0000269|PubMed:32679764, ECO:0000269|PubMed:6489349, ECO:0000269|PubMed:8550562}. |
P08138 | NGFR | S277 | psp | Tumor necrosis factor receptor superfamily member 16 (Gp80-LNGFR) (Low affinity neurotrophin receptor p75NTR) (Low-affinity nerve growth factor receptor) (NGF receptor) (Low-affinity nerve growth factor receptor p75NGFR) (Low-affinity nerve growth factor receptor p75NGR) (p75 ICD) (CD antigen CD271) | Low affinity receptor which can bind to NGF, BDNF, NTF3, and NTF4. Forms a heterodimeric receptor with SORCS2 that binds the precursor forms of NGF, BDNF and NTF3 with high affinity, and has much lower affinity for mature NGF and BDNF (PubMed:24908487). Plays an important role in differentiation and survival of specific neuronal populations during development (By similarity). Can mediate cell survival as well as cell death of neural cells. Plays a role in the inactivation of RHOA (PubMed:26646181). Plays a role in the regulation of the translocation of GLUT4 to the cell surface in adipocytes and skeletal muscle cells in response to insulin, probably by regulating RAB31 activity, and thereby contributes to the regulation of insulin-dependent glucose uptake (By similarity). Necessary for the circadian oscillation of the clock genes BMAL1, PER1, PER2 and NR1D1 in the suprachiasmatic nucleus (SCmgetaN) of the brain and in liver and of the genes involved in glucose and lipid metabolism in the liver (PubMed:23785138). Together with BFAR negatively regulates NF-kappa-B and JNK-related signaling pathways (PubMed:22566094). {ECO:0000250, ECO:0000250|UniProtKB:Q9Z0W1, ECO:0000269|PubMed:14966521, ECO:0000269|PubMed:23785138, ECO:0000269|PubMed:24908487, ECO:0000269|PubMed:26646181, ECO:0000269|PubMed:3022937}. |
P08559 | PDHA1 | S293 | ochoa|psp | Pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial (EC 1.2.4.1) (PDHE1-A type I) | The pyruvate dehydrogenase complex catalyzes the overall conversion of pyruvate to acetyl-CoA and CO(2), and thereby links the glycolytic pathway to the tricarboxylic cycle. {ECO:0000269|PubMed:19081061, ECO:0000269|PubMed:7782287}. |
P0C7P1 | RBMY1D | S176 | ochoa | RNA-binding motif protein, Y chromosome, family 1 member D | RNA-binding protein which may be involved in spermatogenesis. Required for sperm development, possibly by participating in pre-mRNA splicing in the testis. |
P0DJD3 | RBMY1A1 | S176 | ochoa | RNA-binding motif protein, Y chromosome, family 1 member A1 (RNA-binding motif protein 1) (RNA-binding motif protein 2) (Y chromosome RNA recognition motif 1) (hRBMY) | RNA-binding protein involved in pre-mRNA splicing. Required for sperm development. Acts additively with TRA2B to promote exon 7 inclusion of the survival motor neuron SMN. Binds non-specifically to mRNAs. {ECO:0000269|PubMed:12165565, ECO:0000269|PubMed:8269511}. |
P0DJD4 | RBMY1C | S176 | ochoa | RNA-binding motif protein, Y chromosome, family 1 member C | RNA-binding protein involved in pre-mRNA splicing. Required for sperm development. Acts additively with TRA2B to promote exon 7 inclusion of the survival motor neuron SMN. Binds non-specifically to mRNAs. |
P25054 | APC | S2290 | ochoa | Adenomatous polyposis coli protein (Protein APC) (Deleted in polyposis 2.5) | Tumor suppressor. Promotes rapid degradation of CTNNB1 and participates in Wnt signaling as a negative regulator. APC activity is correlated with its phosphorylation state. Activates the GEF activity of SPATA13 and ARHGEF4. Plays a role in hepatocyte growth factor (HGF)-induced cell migration. Required for MMP9 up-regulation via the JNK signaling pathway in colorectal tumor cells. Associates with both microtubules and actin filaments, components of the cytoskeleton (PubMed:17293347). Plays a role in mediating the organization of F-actin into ordered bundles (PubMed:17293347). Functions downstream of Rho GTPases and DIAPH1 to selectively stabilize microtubules (By similarity). Acts as a mediator of ERBB2-dependent stabilization of microtubules at the cell cortex. It is required for the localization of MACF1 to the cell membrane and this localization of MACF1 is critical for its function in microtubule stabilization. {ECO:0000250|UniProtKB:Q61315, ECO:0000269|PubMed:10947987, ECO:0000269|PubMed:17293347, ECO:0000269|PubMed:17599059, ECO:0000269|PubMed:19151759, ECO:0000269|PubMed:19893577, ECO:0000269|PubMed:20937854}. |
P29401 | TKT | S276 | ochoa | Transketolase (TK) (EC 2.2.1.1) | Catalyzes the transfer of a two-carbon ketol group from a ketose donor to an aldose acceptor, via a covalent intermediate with the cofactor thiamine pyrophosphate. {ECO:0000269|PubMed:27259054}. |
P29803 | PDHA2 | S291 | ochoa|psp | Pyruvate dehydrogenase E1 component subunit alpha, testis-specific form, mitochondrial (EC 1.2.4.1) (PDHE1-A type II) | The pyruvate dehydrogenase complex catalyzes the overall conversion of pyruvate to acetyl-CoA and CO(2), and thereby links the glycolytic pathway to the tricarboxylic cycle. {ECO:0000269|PubMed:16436377}. |
P38159 | RBMX | S175 | ochoa | RNA-binding motif protein, X chromosome (Glycoprotein p43) (Heterogeneous nuclear ribonucleoprotein G) (hnRNP G) [Cleaved into: RNA-binding motif protein, X chromosome, N-terminally processed] | RNA-binding protein that plays several role in the regulation of pre- and post-transcriptional processes. Implicated in tissue-specific regulation of gene transcription and alternative splicing of several pre-mRNAs. Binds to and stimulates transcription from the tumor suppressor TXNIP gene promoter; may thus be involved in tumor suppression. When associated with SAFB, binds to and stimulates transcription from the SREBF1 promoter. Associates with nascent mRNAs transcribed by RNA polymerase II. Component of the supraspliceosome complex that regulates pre-mRNA alternative splice site selection. Can either activate or suppress exon inclusion; acts additively with TRA2B to promote exon 7 inclusion of the survival motor neuron SMN2. Represses the splicing of MAPT/Tau exon 10. Binds preferentially to single-stranded 5'-CC[A/C]-rich RNA sequence motifs localized in a single-stranded conformation; probably binds RNA as a homodimer. Binds non-specifically to pre-mRNAs. Also plays a role in the cytoplasmic TNFR1 trafficking pathways; promotes both the IL-1-beta-mediated inducible proteolytic cleavage of TNFR1 ectodomains and the release of TNFR1 exosome-like vesicles to the extracellular compartment. {ECO:0000269|PubMed:12165565, ECO:0000269|PubMed:12761049, ECO:0000269|PubMed:16707624, ECO:0000269|PubMed:18445477, ECO:0000269|PubMed:18541147, ECO:0000269|PubMed:19282290, ECO:0000269|PubMed:21327109}. |
P42331 | ARHGAP25 | S487 | ochoa|psp | Rho GTPase-activating protein 25 (Rho-type GTPase-activating protein 25) | GTPase activator for the Rho-type GTPases by converting them to an inactive GDP-bound state. {ECO:0000250}. |
P52179 | MYOM1 | S1615 | ochoa | Myomesin-1 (190 kDa connectin-associated protein) (190 kDa titin-associated protein) (Myomesin family member 1) | Major component of the vertebrate myofibrillar M band. Binds myosin, titin, and light meromyosin. This binding is dose dependent. |
P54792 | DVL1P1 | S651 | ochoa | Putative segment polarity protein dishevelled homolog DVL1P1 (DSH homolog 1-like) (Segment polarity protein dishevelled homolog DVL-1-like) (Dishevelled-1-like) | May play a role in the signal transduction pathway mediated by multiple Wnt genes. |
P67809 | YBX1 | S136 | ochoa | Y-box-binding protein 1 (YB-1) (CCAAT-binding transcription factor I subunit A) (CBF-A) (DNA-binding protein B) (DBPB) (Enhancer factor I subunit A) (EFI-A) (Nuclease-sensitive element-binding protein 1) (Y-box transcription factor) | DNA- and RNA-binding protein involved in various processes, such as translational repression, RNA stabilization, mRNA splicing, DNA repair and transcription regulation (PubMed:10817758, PubMed:11698476, PubMed:14718551, PubMed:18809583, PubMed:31358969, PubMed:8188694). Predominantly acts as a RNA-binding protein: binds preferentially to the 5'-[CU]CUGCG-3' RNA motif and specifically recognizes mRNA transcripts modified by C5-methylcytosine (m5C) (PubMed:19561594, PubMed:31358969). Promotes mRNA stabilization: acts by binding to m5C-containing mRNAs and recruiting the mRNA stability maintainer ELAVL1, thereby preventing mRNA decay (PubMed:10817758, PubMed:11698476, PubMed:31358969). Component of the CRD-mediated complex that promotes MYC mRNA stability (PubMed:19029303). Contributes to the regulation of translation by modulating the interaction between the mRNA and eukaryotic initiation factors (By similarity). Plays a key role in RNA composition of extracellular exosomes by defining the sorting of small non-coding RNAs, such as tRNAs, Y RNAs, Vault RNAs and miRNAs (PubMed:27559612, PubMed:29073095). Probably sorts RNAs in exosomes by recognizing and binding C5-methylcytosine (m5C)-containing RNAs (PubMed:28341602, PubMed:29073095). Acts as a key effector of epidermal progenitors by preventing epidermal progenitor senescence: acts by regulating the translation of a senescence-associated subset of cytokine mRNAs, possibly by binding to m5C-containing mRNAs (PubMed:29712925). Also involved in pre-mRNA alternative splicing regulation: binds to splice sites in pre-mRNA and regulates splice site selection (PubMed:12604611). Binds to TSC22D1 transcripts, thereby inhibiting their translation and negatively regulating TGF-beta-mediated transcription of COL1A2 (By similarity). Also able to bind DNA: regulates transcription of the multidrug resistance gene MDR1 is enhanced in presence of the APEX1 acetylated form at 'Lys-6' and 'Lys-7' (PubMed:18809583). Binds to promoters that contain a Y-box (5'-CTGATTGGCCAA-3'), such as MDR1 and HLA class II genes (PubMed:18809583, PubMed:8188694). Promotes separation of DNA strands that contain mismatches or are modified by cisplatin (PubMed:14718551). Has endonucleolytic activity and can introduce nicks or breaks into double-stranded DNA, suggesting a role in DNA repair (PubMed:14718551). The secreted form acts as an extracellular mitogen and stimulates cell migration and proliferation (PubMed:19483673). {ECO:0000250|UniProtKB:P62960, ECO:0000250|UniProtKB:Q28618, ECO:0000269|PubMed:10817758, ECO:0000269|PubMed:11698476, ECO:0000269|PubMed:12604611, ECO:0000269|PubMed:14718551, ECO:0000269|PubMed:18809583, ECO:0000269|PubMed:19029303, ECO:0000269|PubMed:19483673, ECO:0000269|PubMed:19561594, ECO:0000269|PubMed:27559612, ECO:0000269|PubMed:28341602, ECO:0000269|PubMed:29073095, ECO:0000269|PubMed:29712925, ECO:0000269|PubMed:31358969, ECO:0000269|PubMed:8188694}. |
P67809 | YBX1 | S209 | ochoa|psp | Y-box-binding protein 1 (YB-1) (CCAAT-binding transcription factor I subunit A) (CBF-A) (DNA-binding protein B) (DBPB) (Enhancer factor I subunit A) (EFI-A) (Nuclease-sensitive element-binding protein 1) (Y-box transcription factor) | DNA- and RNA-binding protein involved in various processes, such as translational repression, RNA stabilization, mRNA splicing, DNA repair and transcription regulation (PubMed:10817758, PubMed:11698476, PubMed:14718551, PubMed:18809583, PubMed:31358969, PubMed:8188694). Predominantly acts as a RNA-binding protein: binds preferentially to the 5'-[CU]CUGCG-3' RNA motif and specifically recognizes mRNA transcripts modified by C5-methylcytosine (m5C) (PubMed:19561594, PubMed:31358969). Promotes mRNA stabilization: acts by binding to m5C-containing mRNAs and recruiting the mRNA stability maintainer ELAVL1, thereby preventing mRNA decay (PubMed:10817758, PubMed:11698476, PubMed:31358969). Component of the CRD-mediated complex that promotes MYC mRNA stability (PubMed:19029303). Contributes to the regulation of translation by modulating the interaction between the mRNA and eukaryotic initiation factors (By similarity). Plays a key role in RNA composition of extracellular exosomes by defining the sorting of small non-coding RNAs, such as tRNAs, Y RNAs, Vault RNAs and miRNAs (PubMed:27559612, PubMed:29073095). Probably sorts RNAs in exosomes by recognizing and binding C5-methylcytosine (m5C)-containing RNAs (PubMed:28341602, PubMed:29073095). Acts as a key effector of epidermal progenitors by preventing epidermal progenitor senescence: acts by regulating the translation of a senescence-associated subset of cytokine mRNAs, possibly by binding to m5C-containing mRNAs (PubMed:29712925). Also involved in pre-mRNA alternative splicing regulation: binds to splice sites in pre-mRNA and regulates splice site selection (PubMed:12604611). Binds to TSC22D1 transcripts, thereby inhibiting their translation and negatively regulating TGF-beta-mediated transcription of COL1A2 (By similarity). Also able to bind DNA: regulates transcription of the multidrug resistance gene MDR1 is enhanced in presence of the APEX1 acetylated form at 'Lys-6' and 'Lys-7' (PubMed:18809583). Binds to promoters that contain a Y-box (5'-CTGATTGGCCAA-3'), such as MDR1 and HLA class II genes (PubMed:18809583, PubMed:8188694). Promotes separation of DNA strands that contain mismatches or are modified by cisplatin (PubMed:14718551). Has endonucleolytic activity and can introduce nicks or breaks into double-stranded DNA, suggesting a role in DNA repair (PubMed:14718551). The secreted form acts as an extracellular mitogen and stimulates cell migration and proliferation (PubMed:19483673). {ECO:0000250|UniProtKB:P62960, ECO:0000250|UniProtKB:Q28618, ECO:0000269|PubMed:10817758, ECO:0000269|PubMed:11698476, ECO:0000269|PubMed:12604611, ECO:0000269|PubMed:14718551, ECO:0000269|PubMed:18809583, ECO:0000269|PubMed:19029303, ECO:0000269|PubMed:19483673, ECO:0000269|PubMed:19561594, ECO:0000269|PubMed:27559612, ECO:0000269|PubMed:28341602, ECO:0000269|PubMed:29073095, ECO:0000269|PubMed:29712925, ECO:0000269|PubMed:31358969, ECO:0000269|PubMed:8188694}. |
Q12888 | TP53BP1 | S96 | ochoa | TP53-binding protein 1 (53BP1) (p53-binding protein 1) (p53BP1) | Double-strand break (DSB) repair protein involved in response to DNA damage, telomere dynamics and class-switch recombination (CSR) during antibody genesis (PubMed:12364621, PubMed:17190600, PubMed:21144835, PubMed:22553214, PubMed:23333306, PubMed:27153538, PubMed:28241136, PubMed:31135337, PubMed:37696958). Plays a key role in the repair of double-strand DNA breaks (DSBs) in response to DNA damage by promoting non-homologous end joining (NHEJ)-mediated repair of DSBs and specifically counteracting the function of the homologous recombination (HR) repair protein BRCA1 (PubMed:22553214, PubMed:23333306, PubMed:23727112, PubMed:27153538, PubMed:31135337). In response to DSBs, phosphorylation by ATM promotes interaction with RIF1 and dissociation from NUDT16L1/TIRR, leading to recruitment to DSBs sites (PubMed:28241136). Recruited to DSBs sites by recognizing and binding histone H2A monoubiquitinated at 'Lys-15' (H2AK15Ub) and histone H4 dimethylated at 'Lys-20' (H4K20me2), two histone marks that are present at DSBs sites (PubMed:17190600, PubMed:23760478, PubMed:27153538, PubMed:28241136). Required for immunoglobulin class-switch recombination (CSR) during antibody genesis, a process that involves the generation of DNA DSBs (PubMed:23345425). Participates in the repair and the orientation of the broken DNA ends during CSR (By similarity). In contrast, it is not required for classic NHEJ and V(D)J recombination (By similarity). Promotes NHEJ of dysfunctional telomeres via interaction with PAXIP1 (PubMed:23727112). {ECO:0000250|UniProtKB:P70399, ECO:0000269|PubMed:12364621, ECO:0000269|PubMed:17190600, ECO:0000269|PubMed:21144835, ECO:0000269|PubMed:22553214, ECO:0000269|PubMed:23333306, ECO:0000269|PubMed:23345425, ECO:0000269|PubMed:23727112, ECO:0000269|PubMed:23760478, ECO:0000269|PubMed:27153538, ECO:0000269|PubMed:28241136, ECO:0000269|PubMed:31135337, ECO:0000269|PubMed:37696958}. |
Q12888 | TP53BP1 | S1618 | ochoa|psp | TP53-binding protein 1 (53BP1) (p53-binding protein 1) (p53BP1) | Double-strand break (DSB) repair protein involved in response to DNA damage, telomere dynamics and class-switch recombination (CSR) during antibody genesis (PubMed:12364621, PubMed:17190600, PubMed:21144835, PubMed:22553214, PubMed:23333306, PubMed:27153538, PubMed:28241136, PubMed:31135337, PubMed:37696958). Plays a key role in the repair of double-strand DNA breaks (DSBs) in response to DNA damage by promoting non-homologous end joining (NHEJ)-mediated repair of DSBs and specifically counteracting the function of the homologous recombination (HR) repair protein BRCA1 (PubMed:22553214, PubMed:23333306, PubMed:23727112, PubMed:27153538, PubMed:31135337). In response to DSBs, phosphorylation by ATM promotes interaction with RIF1 and dissociation from NUDT16L1/TIRR, leading to recruitment to DSBs sites (PubMed:28241136). Recruited to DSBs sites by recognizing and binding histone H2A monoubiquitinated at 'Lys-15' (H2AK15Ub) and histone H4 dimethylated at 'Lys-20' (H4K20me2), two histone marks that are present at DSBs sites (PubMed:17190600, PubMed:23760478, PubMed:27153538, PubMed:28241136). Required for immunoglobulin class-switch recombination (CSR) during antibody genesis, a process that involves the generation of DNA DSBs (PubMed:23345425). Participates in the repair and the orientation of the broken DNA ends during CSR (By similarity). In contrast, it is not required for classic NHEJ and V(D)J recombination (By similarity). Promotes NHEJ of dysfunctional telomeres via interaction with PAXIP1 (PubMed:23727112). {ECO:0000250|UniProtKB:P70399, ECO:0000269|PubMed:12364621, ECO:0000269|PubMed:17190600, ECO:0000269|PubMed:21144835, ECO:0000269|PubMed:22553214, ECO:0000269|PubMed:23333306, ECO:0000269|PubMed:23345425, ECO:0000269|PubMed:23727112, ECO:0000269|PubMed:23760478, ECO:0000269|PubMed:27153538, ECO:0000269|PubMed:28241136, ECO:0000269|PubMed:31135337, ECO:0000269|PubMed:37696958}. |
Q15061 | WDR43 | S427 | ochoa | WD repeat-containing protein 43 (U3 small nucleolar RNA-associated protein 5 homolog) | Ribosome biogenesis factor that coordinates hyperactive transcription and ribogenesis (PubMed:17699751). Part of the small subunit (SSU) processome, first precursor of the small eukaryotic ribosomal subunit. During the assembly of the SSU processome in the nucleolus, many ribosome biogenesis factors, an RNA chaperone and ribosomal proteins associate with the nascent pre-rRNA and work in concert to generate RNA folding, modifications, rearrangements and cleavage as well as targeted degradation of pre-ribosomal RNA by the RNA exosome. Involved in nucleolar processing of pre-18S ribosomal RNA. Required for optimal pre-ribosomal RNA transcription by RNA polymerase I (PubMed:17699751, PubMed:34516797). Essential for stem cell pluripotency and embryonic development. In the nucleoplasm, recruited by promoter-associated/nascent transcripts and transcription to active promoters where it facilitates releases of elongation factor P-TEFb and paused RNA polymerase II to allow transcription elongation and maintain high-level expression of its targets genes (By similarity). {ECO:0000250|UniProtKB:Q6ZQL4, ECO:0000269|PubMed:17699751, ECO:0000269|PubMed:34516797}. |
Q15345 | LRRC41 | S276 | ochoa | Leucine-rich repeat-containing protein 41 (Protein Muf1) | Probable substrate recognition component of an ECS (Elongin BC-CUL2/5-SOCS-box protein) E3 ubiquitin ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins. {ECO:0000269|PubMed:15601820}. |
Q15415 | RBMY1F | S176 | ochoa | RNA-binding motif protein, Y chromosome, family 1 member F/J (Y chromosome RNA recognition motif 2) | RNA-binding protein which may be involved in spermatogenesis. Required for sperm development, possibly by participating in pre-mRNA splicing in the testis. {ECO:0000269|PubMed:8269511}. |
Q15772 | SPEG | S2566 | ochoa | Striated muscle preferentially expressed protein kinase (EC 2.7.11.1) (Aortic preferentially expressed protein 1) (APEG-1) | Isoform 3 may have a role in regulating the growth and differentiation of arterial smooth muscle cells. |
Q29RF7 | PDS5A | S1223 | ochoa | Sister chromatid cohesion protein PDS5 homolog A (Cell proliferation-inducing gene 54 protein) (Sister chromatid cohesion protein 112) (SCC-112) | Probable regulator of sister chromatid cohesion in mitosis which may stabilize cohesin complex association with chromatin. May couple sister chromatid cohesion during mitosis to DNA replication. Cohesion ensures that chromosome partitioning is accurate in both meiotic and mitotic cells and plays an important role in DNA repair. {ECO:0000269|PubMed:15855230, ECO:0000269|PubMed:19907496}. |
Q460N5 | PARP14 | S33 | ochoa | Protein mono-ADP-ribosyltransferase PARP14 (EC 2.4.2.-) (ADP-ribosyltransferase diphtheria toxin-like 8) (ARTD8) (B aggressive lymphoma protein 2) (Poly [ADP-ribose] polymerase 14) (PARP-14) | ADP-ribosyltransferase that mediates mono-ADP-ribosylation of glutamate residues on target proteins (PubMed:16061477, PubMed:18851833, PubMed:25043379, PubMed:27796300). In contrast to PARP1 and PARP2, it is not able to mediate poly-ADP-ribosylation (PubMed:25043379). Has been shown to catalyze the mono-ADP-ribosylation of STAT1 at 'Glu-657' and 'Glu-705', thus decreasing STAT1 phosphorylation which negatively regulates pro-inflammatory cytokine production in macrophages in response to IFNG stimulation (PubMed:27796300). However, the role of ADP-ribosylation in the prevention of STAT1 phosphorylation has been called into question and it has been suggested that the inhibition of phosphorylation may be the result of sumoylation of STAT1 'Lys-703' (PubMed:29858569). Mono-ADP-ribosylates STAT6; enhancing STAT6-dependent transcription (PubMed:27796300). In macrophages, positively regulates MRC1 expression in response to IL4 stimulation by promoting STAT6 phosphorylation (PubMed:27796300). Mono-ADP-ribosylates PARP9 (PubMed:27796300). {ECO:0000269|PubMed:16061477, ECO:0000269|PubMed:18851833, ECO:0000269|PubMed:25043379, ECO:0000269|PubMed:27796300, ECO:0000305|PubMed:29858569}. |
Q5VT52 | RPRD2 | S1099 | ochoa | Regulation of nuclear pre-mRNA domain-containing protein 2 | None |
Q69YH5 | CDCA2 | S24 | ochoa | Cell division cycle-associated protein 2 (Recruits PP1 onto mitotic chromatin at anaphase protein) (Repo-Man) | Regulator of chromosome structure during mitosis required for condensin-depleted chromosomes to retain their compact architecture through anaphase. Acts by mediating the recruitment of phopsphatase PP1-gamma subunit (PPP1CC) to chromatin at anaphase and into the following interphase. At anaphase onset, its association with chromatin targets a pool of PPP1CC to dephosphorylate substrates. {ECO:0000269|PubMed:16492807, ECO:0000269|PubMed:16998479}. |
Q6P0Q8 | MAST2 | S883 | ochoa | Microtubule-associated serine/threonine-protein kinase 2 (EC 2.7.11.1) | Appears to link the dystrophin/utrophin network with microtubule filaments via the syntrophins. Phosphorylation of DMD or UTRN may modulate their affinities for associated proteins. Functions in a multi-protein complex in spermatid maturation. Regulates lipopolysaccharide-induced IL-12 synthesis in macrophages by forming a complex with TRAF6, resulting in the inhibition of TRAF6 NF-kappa-B activation (By similarity). {ECO:0000250}. |
Q6T4R5 | NHS | S533 | ochoa | Actin remodeling regulator NHS (Congenital cataracts and dental anomalies protein) (Nance-Horan syndrome protein) | May function in cell morphology by maintaining the integrity of the circumferential actin ring and controlling lamellipod formation. Involved in the regulation eye, tooth, brain and craniofacial development. {ECO:0000269|PubMed:20332100}. |
Q6ZNL6 | FGD5 | S552 | ochoa | FYVE, RhoGEF and PH domain-containing protein 5 (Zinc finger FYVE domain-containing protein 23) | Activates CDC42, a member of the Ras-like family of Rho- and Rac proteins, by exchanging bound GDP for free GTP. Mediates VEGF-induced CDC42 activation. May regulate proangiogenic action of VEGF in vascular endothelial cells, including network formation, directional movement and proliferation. May play a role in regulating the actin cytoskeleton and cell shape. {ECO:0000269|PubMed:22328776}. |
Q70EL4 | USP43 | S796 | ochoa | Ubiquitin carboxyl-terminal hydrolase 43 (EC 3.4.19.12) (Deubiquitinating enzyme 43) (Ubiquitin thioesterase 43) (Ubiquitin-specific-processing protease 43) | May recognize and hydrolyze the peptide bond at the C-terminal Gly of ubiquitin. Involved in the processing of poly-ubiquitin precursors as well as that of ubiquitinated proteins (By similarity). {ECO:0000250}. |
Q75N03 | CBLL1 | S278 | ochoa | E3 ubiquitin-protein ligase Hakai (EC 2.3.2.27) (Casitas B-lineage lymphoma-transforming sequence-like protein 1) (c-Cbl-like protein 1) (RING finger protein 188) (RING-type E3 ubiquitin transferase Hakai) | E3 ubiquitin-protein ligase that mediates ubiquitination of several tyrosine-phosphorylated Src substrates, including CDH1, CTTN and DOK1 (By similarity). Targets CDH1 for endocytosis and degradation (By similarity). Associated component of the WMM complex, a complex that mediates N6-methyladenosine (m6A) methylation of RNAs, a modification that plays a role in the efficiency of mRNA splicing and RNA processing (PubMed:29507755). Its function in the WMM complex is unknown (PubMed:29507755). {ECO:0000250|UniProtKB:Q9JIY2, ECO:0000269|PubMed:29507755}. |
Q7Z591 | AKNA | S889 | ochoa | Microtubule organization protein AKNA (AT-hook-containing transcription factor) | Centrosomal protein that plays a key role in cell delamination by regulating microtubule organization (By similarity). Required for the delamination and retention of neural stem cells from the subventricular zone during neurogenesis (By similarity). Also regulates the epithelial-to-mesenchymal transition in other epithelial cells (By similarity). Acts by increasing centrosomal microtubule nucleation and recruiting nucleation factors and minus-end stabilizers, thereby destabilizing microtubules at the adherens junctions and mediating constriction of the apical endfoot (By similarity). In addition, may also act as a transcription factor that specifically activates the expression of the CD40 receptor and its ligand CD40L/CD154, two cell surface molecules on lymphocytes that are critical for antigen-dependent-B-cell development (PubMed:11268217). Binds to A/T-rich promoters (PubMed:11268217). It is unclear how it can both act as a microtubule organizer and as a transcription factor; additional evidences are required to reconcile these two apparently contradictory functions (Probable). {ECO:0000250|UniProtKB:Q80VW7, ECO:0000269|PubMed:11268217, ECO:0000305}. |
Q8NFW9 | MYRIP | S295 | ochoa | Rab effector MyRIP (Exophilin-8) (Myosin-VIIa- and Rab-interacting protein) (Synaptotagmin-like protein lacking C2 domains C) (SlaC2-c) (Slp homolog lacking C2 domains c) | Rab effector protein involved in melanosome transport. Serves as link between melanosome-bound RAB27A and the motor proteins MYO5A and MYO7A. May link RAB27A-containing vesicles to actin filaments. Functions as a protein kinase A-anchoring protein (AKAP). May act as a scaffolding protein that links PKA to components of the exocytosis machinery, thus facilitating exocytosis, including insulin release (By similarity). {ECO:0000250}. |
Q8NHV4 | NEDD1 | S426 | ochoa|psp | Protein NEDD1 (Neural precursor cell expressed developmentally down-regulated protein 1) (NEDD-1) | Required for mitosis progression. Promotes the nucleation of microtubules from the spindle. {ECO:0000269|PubMed:19029337, ECO:0000269|PubMed:19509060}. |
Q8WWL2 | SPIRE2 | S387 | ochoa | Protein spire homolog 2 (Spir-2) | Acts as an actin nucleation factor, remains associated with the slow-growing pointed end of the new filament (PubMed:21620703). Involved in intracellular vesicle transport along actin fibers, providing a novel link between actin cytoskeleton dynamics and intracellular transport (By similarity). Required for asymmetric spindle positioning and asymmetric cell division during meiosis (PubMed:21620703). Required for normal formation of the cleavage furrow and for polar body extrusion during female germ cell meiosis (PubMed:21620703). Also acts in the nucleus: together with SPIRE1 and SPIRE2, promotes assembly of nuclear actin filaments in response to DNA damage in order to facilitate movement of chromatin and repair factors after DNA damage (PubMed:26287480). {ECO:0000250|UniProtKB:Q8K1S6, ECO:0000269|PubMed:21620703, ECO:0000269|PubMed:26287480}. |
Q8WY91 | THAP4 | S237 | ochoa | Peroxynitrite isomerase THAP4 (EC 5.99.-.-) (Ferric Homo sapiens nitrobindin) (Hs-Nb(III)) (THAP domain-containing protein 4) | Heme-binding protein able to scavenge peroxynitrite and to protect free L-tyrosine against peroxynitrite-mediated nitration, by acting as a peroxynitrite isomerase that converts peroxynitrite to nitrate. Therefore, this protein likely plays a role in peroxynitrite sensing and in the detoxification of reactive nitrogen and oxygen species (RNS and ROS, respectively). Is able to bind nitric oxide (NO) in vitro, but may act as a sensor of peroxynitrite levels in vivo, possibly modulating the transcriptional activity residing in the N-terminal region. {ECO:0000269|PubMed:30524950, ECO:0000269|PubMed:32295384}. |
Q92997 | DVL3 | S697 | ochoa|psp | Segment polarity protein dishevelled homolog DVL-3 (Dishevelled-3) (DSH homolog 3) | Involved in the signal transduction pathway mediated by multiple Wnt genes. {ECO:0000250|UniProtKB:Q61062}. |
Q96E39 | RBMXL1 | S175 | ochoa | RNA binding motif protein, X-linked-like-1 (Heterogeneous nuclear ribonucleoprotein G-like 1) | RNA-binding protein which may be involved in pre-mRNA splicing. {ECO:0000250}. |
Q96MK2 | RIPOR3 | S24 | ochoa | RIPOR family member 3 | None |
Q96PN7 | TRERF1 | S618 | ochoa | Transcriptional-regulating factor 1 (Breast cancer anti-estrogen resistance 2) (Transcriptional-regulating protein 132) (Zinc finger protein rapa) (Zinc finger transcription factor TReP-132) | Binds DNA and activates transcription of CYP11A1. Interaction with CREBBP and EP300 results in a synergistic transcriptional activation of CYP11A1. {ECO:0000269|PubMed:11349124, ECO:0000269|PubMed:16371131}. |
Q96QB1 | DLC1 | S842 | ochoa | Rho GTPase-activating protein 7 (Deleted in liver cancer 1 protein) (DLC-1) (HP protein) (Rho-type GTPase-activating protein 7) (START domain-containing protein 12) (StARD12) (StAR-related lipid transfer protein 12) | Functions as a GTPase-activating protein for the small GTPases RHOA, RHOB, RHOC and CDC42, terminating their downstream signaling. This induces morphological changes and detachment through cytoskeletal reorganization, playing a critical role in biological processes such as cell migration and proliferation. Also functions in vivo as an activator of the phospholipase PLCD1. Active DLC1 increases cell migration velocity but reduces directionality. Required for growth factor-induced epithelial cell migration; in resting cells, interacts with TNS3 while PTEN interacts with the p85 regulatory subunit of the PI3K kinase complex but growth factor stimulation induces phosphorylation of TNS3 and PTEN, causing them to change their binding preference so that PTEN interacts with DLC1 and TNS3 interacts with p85 (PubMed:26166433). The PTEN-DLC1 complex translocates to the posterior of migrating cells to activate RHOA while the TNS3-p85 complex translocates to the leading edge of migrating cells to promote RAC1 activation (PubMed:26166433). {ECO:0000269|PubMed:18786931, ECO:0000269|PubMed:19170769, ECO:0000269|PubMed:19710422, ECO:0000269|PubMed:26166433}. |
Q96ST3 | SIN3A | S450 | ochoa | Paired amphipathic helix protein Sin3a (Histone deacetylase complex subunit Sin3a) (Transcriptional corepressor Sin3a) | Acts as a transcriptional repressor. Corepressor for REST. Interacts with MXI1 to repress MYC responsive genes and antagonize MYC oncogenic activities. Also interacts with MXD1-MAX heterodimers to repress transcription by tethering SIN3A to DNA. Acts cooperatively with OGT to repress transcription in parallel with histone deacetylation. Involved in the control of the circadian rhythms. Required for the transcriptional repression of circadian target genes, such as PER1, mediated by the large PER complex through histone deacetylation. Cooperates with FOXK1 to regulate cell cycle progression probably by repressing cell cycle inhibitor genes expression (By similarity). Required for cortical neuron differentiation and callosal axon elongation (By similarity). {ECO:0000250|UniProtKB:Q60520, ECO:0000269|PubMed:12150998}. |
Q9BY89 | KIAA1671 | S1156 | ochoa | Uncharacterized protein KIAA1671 | None |
Q9BYB0 | SHANK3 | S1613 | ochoa | SH3 and multiple ankyrin repeat domains protein 3 (Shank3) (Proline-rich synapse-associated protein 2) (ProSAP2) | Major scaffold postsynaptic density protein which interacts with multiple proteins and complexes to orchestrate the dendritic spine and synapse formation, maturation and maintenance. Interconnects receptors of the postsynaptic membrane including NMDA-type and metabotropic glutamate receptors via complexes with GKAP/PSD-95 and HOMER, respectively, and the actin-based cytoskeleton. Plays a role in the structural and functional organization of the dendritic spine and synaptic junction through the interaction with Arp2/3 and WAVE1 complex as well as the promotion of the F-actin clusters. By way of this control of actin dynamics, participates in the regulation of developing neurons growth cone motility and the NMDA receptor-signaling. Also modulates GRIA1 exocytosis and GRM5/MGLUR5 expression and signaling to control the AMPA and metabotropic glutamate receptor-mediated synaptic transmission and plasticity. May be required at an early stage of synapse formation and be inhibited by IGF1 to promote synapse maturation. {ECO:0000269|PubMed:24132240}. |
Q9C0J8 | WDR33 | S1279 | ochoa | pre-mRNA 3' end processing protein WDR33 (WD repeat-containing protein 33) (WD repeat-containing protein of 146 kDa) | Essential for both cleavage and polyadenylation of pre-mRNA 3' ends. {ECO:0000269|PubMed:19217410}. |
Q9H0W5 | CCDC8 | S103 | ochoa | Coiled-coil domain-containing protein 8 | Core component of the 3M complex, a complex required to regulate microtubule dynamics and genome integrity. It is unclear how the 3M complex regulates microtubules, it could act by controlling the level of a microtubule stabilizer (PubMed:24793695, PubMed:24793696). Required for localization of CUL7 to the centrosome (PubMed:24793695). {ECO:0000269|PubMed:24793695, ECO:0000269|PubMed:24793696}. |
Q9H2D6 | TRIOBP | S805 | ochoa | TRIO and F-actin-binding protein (Protein Tara) (TRF1-associated protein of 68 kDa) (Trio-associated repeat on actin) | [Isoform 1]: Regulates actin cytoskeletal organization, cell spreading and cell contraction by directly binding and stabilizing filamentous F-actin and prevents its depolymerization (PubMed:18194665, PubMed:28438837). May also serve as a linker protein to recruit proteins required for F-actin formation and turnover (PubMed:18194665). Essential for correct mitotic progression (PubMed:22820163, PubMed:24692559). {ECO:0000269|PubMed:18194665, ECO:0000269|PubMed:22820163, ECO:0000269|PubMed:24692559, ECO:0000269|PubMed:28438837}.; FUNCTION: [Isoform 5]: Plays a pivotal role in the formation of stereocilia rootlets. {ECO:0000250|UniProtKB:Q99KW3}.; FUNCTION: [Isoform 4]: Plays a pivotal role in the formation of stereocilia rootlets. {ECO:0000250|UniProtKB:Q99KW3}. |
Q9H910 | JPT2 | S45 | ochoa | Jupiter microtubule associated homolog 2 (Hematological and neurological expressed 1-like protein) (HN1-like protein) | Nicotinic acid adenine dinucleotide phosphate (NAADP) binding protein required for NAADP-evoked intracellular calcium release (PubMed:33758061, PubMed:33758062). Confers NAADP-sensitivity to the two pore channels (TPCs) complex (PubMed:33758061). Enables NAADP to activate Ca(2+) release from the endoplasmic reticulum through ryanodine receptors (PubMed:33758062). {ECO:0000269|PubMed:33758061, ECO:0000269|PubMed:33758062}.; FUNCTION: (Microbial infection) Involved in the endolysosomal trafficking of human coronavirus SARS-CoV-2. {ECO:0000269|PubMed:33758061}. |
Q9NPI6 | DCP1A | S451 | ochoa | mRNA-decapping enzyme 1A (EC 3.6.1.62) (Smad4-interacting transcriptional co-activator) (Transcription factor SMIF) | Necessary for the degradation of mRNAs, both in normal mRNA turnover and in nonsense-mediated mRNA decay (PubMed:12417715). Removes the 7-methyl guanine cap structure from mRNA molecules, yielding a 5'-phosphorylated mRNA fragment and 7m-GDP (PubMed:12417715). Contributes to the transactivation of target genes after stimulation by TGFB1 (PubMed:11836524). Essential for embryonic development (PubMed:33813271). {ECO:0000269|PubMed:11836524, ECO:0000269|PubMed:12417715, ECO:0000269|PubMed:33813271}. |
Q9NRM7 | LATS2 | S172 | psp | Serine/threonine-protein kinase LATS2 (EC 2.7.11.1) (Kinase phosphorylated during mitosis protein) (Large tumor suppressor homolog 2) (Serine/threonine-protein kinase kpm) (Warts-like kinase) | Negative regulator of YAP1 in the Hippo signaling pathway that plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis (PubMed:18158288, PubMed:26437443, PubMed:26598551, PubMed:34404733). The core of this pathway is composed of a kinase cascade wherein STK3/MST2 and STK4/MST1, in complex with its regulatory protein SAV1, phosphorylates and activates LATS1/2 in complex with its regulatory protein MOB1, which in turn phosphorylates and inactivates YAP1 oncoprotein and WWTR1/TAZ (PubMed:26437443, PubMed:26598551, PubMed:34404733). Phosphorylation of YAP1 by LATS2 inhibits its translocation into the nucleus to regulate cellular genes important for cell proliferation, cell death, and cell migration (PubMed:26598551, PubMed:34404733). Also phosphorylates YAP1 in response to cell contact inhibition-driven WWP1 ubiquitination of AMOTL2, which results in LATS2 activation (PubMed:34404733). Acts as a tumor suppressor which plays a critical role in centrosome duplication, maintenance of mitotic fidelity and genomic stability (PubMed:10871863). Negatively regulates G1/S transition by down-regulating cyclin E/CDK2 kinase activity (PubMed:12853976). Negative regulator of the androgen receptor (PubMed:15131260). Phosphorylates SNAI1 in the nucleus leading to its nuclear retention and stabilization, which enhances its epithelial-mesenchymal transition and tumor cell invasion/migration activities (PubMed:21952048). This tumor-promoting activity is independent of its effects upon YAP1 or WWTR1/TAZ (PubMed:21952048). Acts as an activator of the NLRP3 inflammasome by mediating phosphorylation of 'Ser-265' of NLRP3 following NLRP3 palmitoylation, promoting NLRP3 activation by NEK7 (PubMed:39173637). {ECO:0000269|PubMed:10871863, ECO:0000269|PubMed:12853976, ECO:0000269|PubMed:15131260, ECO:0000269|PubMed:18158288, ECO:0000269|PubMed:21952048, ECO:0000269|PubMed:26437443, ECO:0000269|PubMed:26598551, ECO:0000269|PubMed:34404733, ECO:0000269|PubMed:39173637}. |
Q9NWH9 | SLTM | S815 | ochoa | SAFB-like transcription modulator (Modulator of estrogen-induced transcription) | When overexpressed, acts as a general inhibitor of transcription that eventually leads to apoptosis. {ECO:0000250}. |
Q9P206 | NHSL3 | S912 | ochoa | NHS-like protein 3 | Able to directly activate the TNF-NFkappaB signaling pathway. {ECO:0000269|PubMed:32854746}. |
Q9UMY4 | SNX12 | S73 | ochoa | Sorting nexin-12 | May be involved in several stages of intracellular trafficking. {ECO:0000250}. |
Q9Y3R5 | DOP1B | S1169 | ochoa | Protein DOP1B | May play a role in regulating membrane trafficking of cargo proteins. Together with ATP9A and MON2, regulates SNX3 retromer-mediated endosomal sorting of WLS away from lysosomal degradation. {ECO:0000269|PubMed:30213940}. |
Q9Y450 | HBS1L | S213 | ochoa | HBS1-like protein (EC 3.6.5.-) (ERFS) | GTPase component of the Pelota-HBS1L complex, a complex that recognizes stalled ribosomes and triggers the No-Go Decay (NGD) pathway (PubMed:21448132, PubMed:23667253, PubMed:27863242). The Pelota-HBS1L complex recognizes ribosomes stalled at the 3' end of an mRNA and engages stalled ribosomes by destabilizing mRNA in the mRNA channel (PubMed:27863242). Following mRNA extraction from stalled ribosomes by the SKI complex, the Pelota-HBS1L complex promotes recruitment of ABCE1, which drives the disassembly of stalled ribosomes, followed by degradation of damaged mRNAs as part of the NGD pathway (PubMed:21448132, PubMed:32006463). {ECO:0000269|PubMed:21448132, ECO:0000269|PubMed:23667253, ECO:0000269|PubMed:27863242, ECO:0000269|PubMed:32006463}. |
P08174 | CD55 | S54 | Sugiyama | Complement decay-accelerating factor (CD antigen CD55) | This protein recognizes C4b and C3b fragments that condense with cell-surface hydroxyl or amino groups when nascent C4b and C3b are locally generated during C4 and c3 activation. Interaction of daf with cell-associated C4b and C3b polypeptides interferes with their ability to catalyze the conversion of C2 and factor B to enzymatically active C2a and Bb and thereby prevents the formation of C4b2a and C3bBb, the amplification convertases of the complement cascade (PubMed:7525274). Inhibits complement activation by destabilizing and preventing the formation of C3 and C5 convertases, which prevents complement damage (PubMed:28657829). {ECO:0000269|PubMed:7525274, ECO:0000305|PubMed:28657829}.; FUNCTION: (Microbial infection) Acts as a receptor for Coxsackievirus A21, coxsackieviruses B1, B3 and B5. {ECO:0000269|PubMed:9151867}.; FUNCTION: (Microbial infection) Acts as a receptor for Human enterovirus 70 and D68 (Probable). {ECO:0000269|PubMed:8764022}.; FUNCTION: (Microbial infection) Acts as a receptor for Human echoviruses 6, 7, 11, 12, 20 and 21. {ECO:0000269|PubMed:7525274, ECO:0000305|PubMed:12409401}. |
Download
reactome_id | name | p | -log10_p |
---|---|---|---|
R-HSA-5368598 | Negative regulation of TCF-dependent signaling by DVL-interacting proteins | 0.000002 | 5.811 |
R-HSA-201688 | WNT mediated activation of DVL | 0.000021 | 4.680 |
R-HSA-4641262 | Disassembly of the destruction complex and recruitment of AXIN to the membrane | 0.000014 | 4.863 |
R-HSA-8936459 | RUNX1 regulates genes involved in megakaryocyte differentiation and platelet fun... | 0.000020 | 4.689 |
R-HSA-9673324 | WNT5:FZD7-mediated leishmania damping | 0.000094 | 4.025 |
R-HSA-9664420 | Killing mechanisms | 0.000094 | 4.025 |
R-HSA-4641258 | Degradation of DVL | 0.000934 | 3.030 |
R-HSA-201681 | TCF dependent signaling in response to WNT | 0.001794 | 2.746 |
R-HSA-9818028 | NFE2L2 regulates pentose phosphate pathway genes | 0.001953 | 2.709 |
R-HSA-9861559 | PDH complex synthesizes acetyl-CoA from PYR | 0.002495 | 2.603 |
R-HSA-195721 | Signaling by WNT | 0.002457 | 2.610 |
R-HSA-5467333 | APC truncation mutants are not K63 polyubiquitinated | 0.004276 | 2.369 |
R-HSA-9675151 | Disorders of Developmental Biology | 0.003765 | 2.424 |
R-HSA-2028269 | Signaling by Hippo | 0.004120 | 2.385 |
R-HSA-429914 | Deadenylation-dependent mRNA decay | 0.003075 | 2.512 |
R-HSA-8878171 | Transcriptional regulation by RUNX1 | 0.004160 | 2.381 |
R-HSA-4086400 | PCP/CE pathway | 0.006138 | 2.212 |
R-HSA-204174 | Regulation of pyruvate dehydrogenase (PDH) complex | 0.010063 | 1.997 |
R-HSA-205017 | NFG and proNGF binds to p75NTR | 0.012774 | 1.894 |
R-HSA-162582 | Signal Transduction | 0.014600 | 1.836 |
R-HSA-3769402 | Deactivation of the beta-catenin transactivating complex | 0.015516 | 1.809 |
R-HSA-209563 | Axonal growth stimulation | 0.021200 | 1.674 |
R-HSA-9944997 | Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | 0.021200 | 1.674 |
R-HSA-9944971 | Loss of Function of KMT2D in Kabuki Syndrome | 0.021200 | 1.674 |
R-HSA-205025 | NADE modulates death signalling | 0.025386 | 1.595 |
R-HSA-9017802 | Noncanonical activation of NOTCH3 | 0.033707 | 1.472 |
R-HSA-2470946 | Cohesin Loading onto Chromatin | 0.041957 | 1.377 |
R-HSA-193692 | Regulated proteolysis of p75NTR | 0.050138 | 1.300 |
R-HSA-2468052 | Establishment of Sister Chromatid Cohesion | 0.054202 | 1.266 |
R-HSA-4839744 | Signaling by APC mutants | 0.058250 | 1.235 |
R-HSA-5467337 | APC truncation mutants have impaired AXIN binding | 0.058250 | 1.235 |
R-HSA-5467340 | AXIN missense mutants destabilize the destruction complex | 0.058250 | 1.235 |
R-HSA-5467348 | Truncations of AMER1 destabilize the destruction complex | 0.058250 | 1.235 |
R-HSA-5339716 | Signaling by GSK3beta mutants | 0.062280 | 1.206 |
R-HSA-209543 | p75NTR recruits signalling complexes | 0.066293 | 1.179 |
R-HSA-4839743 | Signaling by CTNNB1 phospho-site mutants | 0.066293 | 1.179 |
R-HSA-5358751 | CTNNB1 S45 mutants aren't phosphorylated | 0.066293 | 1.179 |
R-HSA-5358752 | CTNNB1 T41 mutants aren't phosphorylated | 0.066293 | 1.179 |
R-HSA-5358749 | CTNNB1 S37 mutants aren't phosphorylated | 0.066293 | 1.179 |
R-HSA-5358747 | CTNNB1 S33 mutants aren't phosphorylated | 0.066293 | 1.179 |
R-HSA-380284 | Loss of proteins required for interphase microtubule organization from the centr... | 0.037535 | 1.426 |
R-HSA-380259 | Loss of Nlp from mitotic centrosomes | 0.037535 | 1.426 |
R-HSA-8854518 | AURKA Activation by TPX2 | 0.040443 | 1.393 |
R-HSA-380270 | Recruitment of mitotic centrosome proteins and complexes | 0.047547 | 1.323 |
R-HSA-380287 | Centrosome maturation | 0.049655 | 1.304 |
R-HSA-380320 | Recruitment of NuMA to mitotic centrosomes | 0.065306 | 1.185 |
R-HSA-5620912 | Anchoring of the basal body to the plasma membrane | 0.067662 | 1.170 |
R-HSA-193697 | p75NTR regulates axonogenesis | 0.050138 | 1.300 |
R-HSA-193634 | Axonal growth inhibition (RHOA activation) | 0.046056 | 1.337 |
R-HSA-163754 | Insulin effects increased synthesis of Xylulose-5-Phosphate | 0.041957 | 1.377 |
R-HSA-9022538 | Loss of MECP2 binding ability to 5mC-DNA | 0.021200 | 1.674 |
R-HSA-111446 | Activation of BIM and translocation to mitochondria | 0.021200 | 1.674 |
R-HSA-193681 | Ceramide signalling | 0.033707 | 1.472 |
R-HSA-209560 | NF-kB is activated and signals survival | 0.062280 | 1.206 |
R-HSA-68884 | Mitotic Telophase/Cytokinesis | 0.062280 | 1.206 |
R-HSA-4839735 | Signaling by AXIN mutants | 0.062280 | 1.206 |
R-HSA-4839748 | Signaling by AMER1 mutants | 0.062280 | 1.206 |
R-HSA-68877 | Mitotic Prometaphase | 0.063039 | 1.200 |
R-HSA-427413 | NoRC negatively regulates rRNA expression | 0.045473 | 1.342 |
R-HSA-8876493 | InlA-mediated entry of Listeria monocytogenes into host cells | 0.058250 | 1.235 |
R-HSA-193670 | p75NTR negatively regulates cell cycle via SC1 | 0.025386 | 1.595 |
R-HSA-9706019 | RHOBTB3 ATPase cycle | 0.058250 | 1.235 |
R-HSA-2565942 | Regulation of PLK1 Activity at G2/M Transition | 0.059543 | 1.225 |
R-HSA-3858494 | Beta-catenin independent WNT signaling | 0.028246 | 1.549 |
R-HSA-9022702 | MECP2 regulates transcription of neuronal ligands | 0.054202 | 1.266 |
R-HSA-5250941 | Negative epigenetic regulation of rRNA expression | 0.055069 | 1.259 |
R-HSA-9005895 | Pervasive developmental disorders | 0.066293 | 1.179 |
R-HSA-9697154 | Disorders of Nervous System Development | 0.066293 | 1.179 |
R-HSA-9005891 | Loss of function of MECP2 in Rett syndrome | 0.066293 | 1.179 |
R-HSA-9861718 | Regulation of pyruvate metabolism | 0.022740 | 1.643 |
R-HSA-70268 | Pyruvate metabolism | 0.064139 | 1.193 |
R-HSA-9659379 | Sensory processing of sound | 0.053970 | 1.268 |
R-HSA-9662360 | Sensory processing of sound by inner hair cells of the cochlea | 0.042428 | 1.372 |
R-HSA-9662361 | Sensory processing of sound by outer hair cells of the cochlea | 0.031084 | 1.507 |
R-HSA-9683610 | Maturation of nucleoprotein | 0.070290 | 1.153 |
R-HSA-3000171 | Non-integrin membrane-ECM interactions | 0.049655 | 1.304 |
R-HSA-5362517 | Signaling by Retinoic Acid | 0.034711 | 1.460 |
R-HSA-8953854 | Metabolism of RNA | 0.073497 | 1.134 |
R-HSA-205043 | NRIF signals cell death from the nucleus | 0.074269 | 1.129 |
R-HSA-196299 | Beta-catenin phosphorylation cascade | 0.078232 | 1.107 |
R-HSA-77595 | Processing of Intronless Pre-mRNAs | 0.086107 | 1.065 |
R-HSA-5083635 | Defective B3GALTL causes PpS | 0.154066 | 0.812 |
R-HSA-5173214 | O-glycosylation of TSR domain-containing proteins | 0.172043 | 0.764 |
R-HSA-72165 | mRNA Splicing - Minor Pathway | 0.206875 | 0.684 |
R-HSA-72187 | mRNA 3'-end processing | 0.227076 | 0.644 |
R-HSA-193639 | p75NTR signals via NF-kB | 0.078232 | 1.107 |
R-HSA-5099900 | WNT5A-dependent internalization of FZD4 | 0.082178 | 1.085 |
R-HSA-2500257 | Resolution of Sister Chromatid Cohesion | 0.114282 | 0.942 |
R-HSA-72203 | Processing of Capped Intron-Containing Pre-mRNA | 0.137027 | 0.863 |
R-HSA-9820841 | M-decay: degradation of maternal mRNAs by maternally stored factors | 0.186153 | 0.730 |
R-HSA-4791275 | Signaling by WNT in cancer | 0.150425 | 0.823 |
R-HSA-75067 | Processing of Capped Intronless Pre-mRNA | 0.120734 | 0.918 |
R-HSA-6807878 | COPI-mediated anterograde transport | 0.077360 | 1.111 |
R-HSA-5620924 | Intraflagellar transport | 0.213666 | 0.670 |
R-HSA-9766229 | Degradation of CDH1 | 0.217040 | 0.663 |
R-HSA-4608870 | Asymmetric localization of PCP proteins | 0.203458 | 0.692 |
R-HSA-2467813 | Separation of Sister Chromatids | 0.183532 | 0.736 |
R-HSA-9701898 | STAT3 nuclear events downstream of ALK signaling | 0.078232 | 1.107 |
R-HSA-430039 | mRNA decay by 5' to 3' exoribonuclease | 0.086107 | 1.065 |
R-HSA-429958 | mRNA decay by 3' to 5' exoribonuclease | 0.097796 | 1.010 |
R-HSA-159231 | Transport of Mature mRNA Derived from an Intronless Transcript | 0.179128 | 0.747 |
R-HSA-9646399 | Aggrephagy | 0.182648 | 0.738 |
R-HSA-5693571 | Nonhomologous End-Joining (NHEJ) | 0.213666 | 0.670 |
R-HSA-5617833 | Cilium Assembly | 0.225633 | 0.647 |
R-HSA-212165 | Epigenetic regulation of gene expression | 0.182155 | 0.740 |
R-HSA-450513 | Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | 0.078232 | 1.107 |
R-HSA-3238698 | WNT ligand biogenesis and trafficking | 0.113152 | 0.946 |
R-HSA-429947 | Deadenylation of mRNA | 0.120734 | 0.918 |
R-HSA-5656169 | Termination of translesion DNA synthesis | 0.139408 | 0.856 |
R-HSA-6794361 | Neurexins and neuroligins | 0.227076 | 0.644 |
R-HSA-71336 | Pentose phosphate pathway | 0.179128 | 0.747 |
R-HSA-450385 | Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | 0.078232 | 1.107 |
R-HSA-8876384 | Listeria monocytogenes entry into host cells | 0.109338 | 0.961 |
R-HSA-9022699 | MECP2 regulates neuronal receptors and channels | 0.128251 | 0.892 |
R-HSA-199977 | ER to Golgi Anterograde Transport | 0.157714 | 0.802 |
R-HSA-3214841 | PKMTs methylate histone lysines | 0.186153 | 0.730 |
R-HSA-69275 | G2/M Transition | 0.219336 | 0.659 |
R-HSA-9824594 | Regulation of MITF-M-dependent genes involved in apoptosis | 0.105507 | 0.977 |
R-HSA-9013507 | NOTCH3 Activation and Transmission of Signal to the Nucleus | 0.113152 | 0.946 |
R-HSA-453274 | Mitotic G2-G2/M phases | 0.222482 | 0.653 |
R-HSA-159234 | Transport of Mature mRNAs Derived from Intronless Transcripts | 0.182648 | 0.738 |
R-HSA-9825892 | Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | 0.109338 | 0.961 |
R-HSA-201556 | Signaling by ALK | 0.179128 | 0.747 |
R-HSA-2173796 | SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | 0.172043 | 0.764 |
R-HSA-9694631 | Maturation of nucleoprotein | 0.097796 | 1.010 |
R-HSA-6804115 | TP53 regulates transcription of additional cell cycle genes whose exact role in ... | 0.113152 | 0.946 |
R-HSA-9022692 | Regulation of MECP2 expression and activity | 0.154066 | 0.812 |
R-HSA-5689896 | Ovarian tumor domain proteases | 0.172043 | 0.764 |
R-HSA-110313 | Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA templa... | 0.186153 | 0.730 |
R-HSA-3000170 | Syndecan interactions | 0.116951 | 0.932 |
R-HSA-9772755 | Formation of WDR5-containing histone-modifying complexes | 0.164898 | 0.783 |
R-HSA-9824443 | Parasitic Infection Pathways | 0.138985 | 0.857 |
R-HSA-9658195 | Leishmania infection | 0.138985 | 0.857 |
R-HSA-264876 | Insulin processing | 0.131986 | 0.879 |
R-HSA-9615017 | FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | 0.189643 | 0.722 |
R-HSA-73893 | DNA Damage Bypass | 0.217040 | 0.663 |
R-HSA-114452 | Activation of BH3-only proteins | 0.143096 | 0.844 |
R-HSA-9856651 | MITF-M-dependent gene expression | 0.162218 | 0.790 |
R-HSA-9824585 | Regulation of MITF-M-dependent genes involved in pigmentation | 0.203458 | 0.692 |
R-HSA-8853659 | RET signaling | 0.168478 | 0.773 |
R-HSA-9683701 | Translation of Structural Proteins | 0.189643 | 0.722 |
R-HSA-111465 | Apoptotic cleavage of cellular proteins | 0.150425 | 0.823 |
R-HSA-9759194 | Nuclear events mediated by NFE2L2 | 0.114282 | 0.942 |
R-HSA-75153 | Apoptotic execution phase | 0.206875 | 0.684 |
R-HSA-9711123 | Cellular response to chemical stress | 0.126434 | 0.898 |
R-HSA-9755511 | KEAP1-NFE2L2 pathway | 0.163725 | 0.786 |
R-HSA-109581 | Apoptosis | 0.180460 | 0.744 |
R-HSA-72163 | mRNA Splicing - Major Pathway | 0.231943 | 0.635 |
R-HSA-6811436 | COPI-independent Golgi-to-ER retrograde traffic | 0.236986 | 0.625 |
R-HSA-9012852 | Signaling by NOTCH3 | 0.236986 | 0.625 |
R-HSA-193648 | NRAGE signals death through JNK | 0.240262 | 0.619 |
R-HSA-2173793 | Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | 0.240262 | 0.619 |
R-HSA-109606 | Intrinsic Pathway for Apoptosis | 0.240262 | 0.619 |
R-HSA-9764561 | Regulation of CDH1 Function | 0.243523 | 0.613 |
R-HSA-6791312 | TP53 Regulates Transcription of Cell Cycle Genes | 0.243523 | 0.613 |
R-HSA-948021 | Transport to the Golgi and subsequent modification | 0.244599 | 0.612 |
R-HSA-201722 | Formation of the beta-catenin:TCF transactivating complex | 0.246771 | 0.608 |
R-HSA-68886 | M Phase | 0.248933 | 0.604 |
R-HSA-72172 | mRNA Splicing | 0.249354 | 0.603 |
R-HSA-5693565 | Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at... | 0.250005 | 0.602 |
R-HSA-5357801 | Programmed Cell Death | 0.250940 | 0.600 |
R-HSA-73856 | RNA Polymerase II Transcription Termination | 0.256432 | 0.591 |
R-HSA-186797 | Signaling by PDGF | 0.259625 | 0.586 |
R-HSA-6790901 | rRNA modification in the nucleus and cytosol | 0.262804 | 0.580 |
R-HSA-9730414 | MITF-M-regulated melanocyte development | 0.263636 | 0.579 |
R-HSA-68882 | Mitotic Anaphase | 0.268400 | 0.571 |
R-HSA-2555396 | Mitotic Metaphase and Anaphase | 0.269988 | 0.569 |
R-HSA-5693606 | DNA Double Strand Break Response | 0.275388 | 0.560 |
R-HSA-196807 | Nicotinate metabolism | 0.275388 | 0.560 |
R-HSA-8951664 | Neddylation | 0.276340 | 0.559 |
R-HSA-3371497 | HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of lig... | 0.278501 | 0.555 |
R-HSA-195253 | Degradation of beta-catenin by the destruction complex | 0.284687 | 0.546 |
R-HSA-3906995 | Diseases associated with O-glycosylation of proteins | 0.287761 | 0.541 |
R-HSA-450531 | Regulation of mRNA stability by proteins that bind AU-rich elements | 0.290821 | 0.536 |
R-HSA-597592 | Post-translational protein modification | 0.290942 | 0.536 |
R-HSA-204998 | Cell death signalling via NRAGE, NRIF and NADE | 0.293869 | 0.532 |
R-HSA-69473 | G2/M DNA damage checkpoint | 0.296903 | 0.527 |
R-HSA-9694635 | Translation of Structural Proteins | 0.305930 | 0.514 |
R-HSA-216083 | Integrin cell surface interactions | 0.308914 | 0.510 |
R-HSA-73857 | RNA Polymerase II Transcription | 0.312088 | 0.506 |
R-HSA-5693607 | Processing of DNA double-strand break ends | 0.317788 | 0.498 |
R-HSA-72202 | Transport of Mature Transcript to Cytoplasm | 0.320722 | 0.494 |
R-HSA-9707564 | Cytoprotection by HMOX1 | 0.323642 | 0.490 |
R-HSA-6794362 | Protein-protein interactions at synapses | 0.329447 | 0.482 |
R-HSA-5688426 | Deubiquitination | 0.330086 | 0.481 |
R-HSA-141424 | Amplification of signal from the kinetochores | 0.332331 | 0.478 |
R-HSA-141444 | Amplification of signal from unattached kinetochores via a MAD2 inhibitory si... | 0.332331 | 0.478 |
R-HSA-69620 | Cell Cycle Checkpoints | 0.334790 | 0.475 |
R-HSA-6807505 | RNA polymerase II transcribes snRNA genes | 0.335202 | 0.475 |
R-HSA-6798695 | Neutrophil degranulation | 0.336543 | 0.473 |
R-HSA-9663891 | Selective autophagy | 0.340909 | 0.467 |
R-HSA-392499 | Metabolism of proteins | 0.344799 | 0.462 |
R-HSA-373080 | Class B/2 (Secretin family receptors) | 0.346567 | 0.460 |
R-HSA-9954714 | PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | 0.349379 | 0.457 |
R-HSA-8986944 | Transcriptional Regulation by MECP2 | 0.349379 | 0.457 |
R-HSA-9772573 | Late SARS-CoV-2 Infection Events | 0.354966 | 0.450 |
R-HSA-9837999 | Mitochondrial protein degradation | 0.360505 | 0.443 |
R-HSA-170834 | Signaling by TGF-beta Receptor Complex | 0.371444 | 0.430 |
R-HSA-193704 | p75 NTR receptor-mediated signalling | 0.376844 | 0.424 |
R-HSA-9614085 | FOXO-mediated transcription | 0.376844 | 0.424 |
R-HSA-69618 | Mitotic Spindle Checkpoint | 0.379527 | 0.421 |
R-HSA-1640170 | Cell Cycle | 0.381069 | 0.419 |
R-HSA-8856825 | Cargo recognition for clathrin-mediated endocytosis | 0.390145 | 0.409 |
R-HSA-5617472 | Activation of anterior HOX genes in hindbrain development during early embryogen... | 0.392771 | 0.406 |
R-HSA-5619507 | Activation of HOX genes during differentiation | 0.392771 | 0.406 |
R-HSA-2672351 | Stimuli-sensing channels | 0.403165 | 0.395 |
R-HSA-9648025 | EML4 and NUDC in mitotic spindle formation | 0.405737 | 0.392 |
R-HSA-975957 | Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | 0.413385 | 0.384 |
R-HSA-927802 | Nonsense-Mediated Decay (NMD) | 0.413385 | 0.384 |
R-HSA-5693567 | HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | 0.418429 | 0.378 |
R-HSA-1852241 | Organelle biogenesis and maintenance | 0.429290 | 0.367 |
R-HSA-2980736 | Peptide hormone metabolism | 0.430855 | 0.366 |
R-HSA-5693538 | Homology Directed Repair | 0.433308 | 0.363 |
R-HSA-1474244 | Extracellular matrix organization | 0.445369 | 0.351 |
R-HSA-9816359 | Maternal to zygotic transition (MZT) | 0.445420 | 0.351 |
R-HSA-2132295 | MHC class II antigen presentation | 0.445420 | 0.351 |
R-HSA-977606 | Regulation of Complement cascade | 0.450193 | 0.347 |
R-HSA-9851695 | Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | 0.452565 | 0.344 |
R-HSA-9841922 | MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesi... | 0.452565 | 0.344 |
R-HSA-9818564 | Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | 0.452565 | 0.344 |
R-HSA-114608 | Platelet degranulation | 0.457277 | 0.340 |
R-HSA-69481 | G2/M Checkpoints | 0.457277 | 0.340 |
R-HSA-1428517 | Aerobic respiration and respiratory electron transport | 0.459773 | 0.337 |
R-HSA-69278 | Cell Cycle, Mitotic | 0.462534 | 0.335 |
R-HSA-8856688 | Golgi-to-ER retrograde transport | 0.471176 | 0.327 |
R-HSA-76005 | Response to elevated platelet cytosolic Ca2+ | 0.473458 | 0.325 |
R-HSA-163685 | Integration of energy metabolism | 0.482490 | 0.317 |
R-HSA-5173105 | O-linked glycosylation | 0.484724 | 0.315 |
R-HSA-74160 | Gene expression (Transcription) | 0.485340 | 0.314 |
R-HSA-73894 | DNA Repair | 0.486549 | 0.313 |
R-HSA-9948299 | Ribosome-associated quality control | 0.486949 | 0.313 |
R-HSA-9006931 | Signaling by Nuclear Receptors | 0.490703 | 0.309 |
R-HSA-1632852 | Macroautophagy | 0.493565 | 0.307 |
R-HSA-8856828 | Clathrin-mediated endocytosis | 0.500098 | 0.301 |
R-HSA-166658 | Complement cascade | 0.504407 | 0.297 |
R-HSA-69242 | S Phase | 0.510802 | 0.292 |
R-HSA-212436 | Generic Transcription Pathway | 0.516775 | 0.287 |
R-HSA-5693532 | DNA Double-Strand Break Repair | 0.521280 | 0.283 |
R-HSA-9917777 | Epigenetic regulation by WDR5-containing histone modifying complexes | 0.523349 | 0.281 |
R-HSA-73887 | Death Receptor Signaling | 0.523349 | 0.281 |
R-HSA-9612973 | Autophagy | 0.527460 | 0.278 |
R-HSA-400206 | Regulation of lipid metabolism by PPARalpha | 0.529502 | 0.276 |
R-HSA-877300 | Interferon gamma signaling | 0.533562 | 0.273 |
R-HSA-9006936 | Signaling by TGFB family members | 0.535578 | 0.271 |
R-HSA-199991 | Membrane Trafficking | 0.550574 | 0.259 |
R-HSA-6791226 | Major pathway of rRNA processing in the nucleolus and cytosol | 0.557201 | 0.254 |
R-HSA-9764274 | Regulation of Expression and Function of Type I Classical Cadherins | 0.562924 | 0.250 |
R-HSA-9764265 | Regulation of CDH1 Expression and Function | 0.562924 | 0.250 |
R-HSA-5689880 | Ub-specific processing proteases | 0.562924 | 0.250 |
R-HSA-983231 | Factors involved in megakaryocyte development and platelet production | 0.566699 | 0.247 |
R-HSA-9678108 | SARS-CoV-1 Infection | 0.566699 | 0.247 |
R-HSA-446203 | Asparagine N-linked glycosylation | 0.569308 | 0.245 |
R-HSA-3781865 | Diseases of glycosylation | 0.583291 | 0.234 |
R-HSA-8868773 | rRNA processing in the nucleus and cytosol | 0.590463 | 0.229 |
R-HSA-983712 | Ion channel transport | 0.592237 | 0.228 |
R-HSA-9609690 | HCMV Early Events | 0.604444 | 0.219 |
R-HSA-9759476 | Regulation of Homotypic Cell-Cell Adhesion | 0.604444 | 0.219 |
R-HSA-6811442 | Intra-Golgi and retrograde Golgi-to-ER traffic | 0.611257 | 0.214 |
R-HSA-418990 | Adherens junctions interactions | 0.642071 | 0.192 |
R-HSA-2262752 | Cellular responses to stress | 0.657861 | 0.182 |
R-HSA-196849 | Metabolism of water-soluble vitamins and cofactors | 0.660279 | 0.180 |
R-HSA-72312 | rRNA processing | 0.663224 | 0.178 |
R-HSA-3247509 | Chromatin modifying enzymes | 0.666143 | 0.176 |
R-HSA-157118 | Signaling by NOTCH | 0.674753 | 0.171 |
R-HSA-4839726 | Chromatin organization | 0.687259 | 0.163 |
R-HSA-9609646 | HCMV Infection | 0.688618 | 0.162 |
R-HSA-421270 | Cell-cell junction organization | 0.689973 | 0.161 |
R-HSA-5653656 | Vesicle-mediated transport | 0.696109 | 0.157 |
R-HSA-76002 | Platelet activation, signaling and aggregation | 0.719563 | 0.143 |
R-HSA-446728 | Cell junction organization | 0.724417 | 0.140 |
R-HSA-983168 | Antigen processing: Ubiquitination & Proteasome degradation | 0.729189 | 0.137 |
R-HSA-8953897 | Cellular responses to stimuli | 0.744961 | 0.128 |
R-HSA-5663205 | Infectious disease | 0.755230 | 0.122 |
R-HSA-9006934 | Signaling by Receptor Tyrosine Kinases | 0.760506 | 0.119 |
R-HSA-1500931 | Cell-Cell communication | 0.766591 | 0.115 |
R-HSA-9694516 | SARS-CoV-2 Infection | 0.798009 | 0.098 |
R-HSA-1643685 | Disease | 0.802830 | 0.095 |
R-HSA-196854 | Metabolism of vitamins and cofactors | 0.810874 | 0.091 |
R-HSA-983169 | Class I MHC mediated antigen processing & presentation | 0.826780 | 0.083 |
R-HSA-913531 | Interferon Signaling | 0.826780 | 0.083 |
R-HSA-9824439 | Bacterial Infection Pathways | 0.832029 | 0.080 |
R-HSA-5668914 | Diseases of metabolism | 0.857277 | 0.067 |
R-HSA-72766 | Translation | 0.858530 | 0.066 |
R-HSA-109582 | Hemostasis | 0.865450 | 0.063 |
R-HSA-71387 | Metabolism of carbohydrates and carbohydrate derivatives | 0.873861 | 0.059 |
R-HSA-3700989 | Transcriptional Regulation by TP53 | 0.879311 | 0.056 |
R-HSA-112316 | Neuronal System | 0.880901 | 0.055 |
R-HSA-5663202 | Diseases of signal transduction by growth factor receptors and second messengers | 0.903268 | 0.044 |
R-HSA-422475 | Axon guidance | 0.915323 | 0.038 |
R-HSA-9679506 | SARS-CoV Infections | 0.919002 | 0.037 |
R-HSA-9675108 | Nervous system development | 0.928168 | 0.032 |
R-HSA-500792 | GPCR ligand binding | 0.930372 | 0.031 |
R-HSA-1266738 | Developmental Biology | 0.935167 | 0.029 |
R-HSA-168249 | Innate Immune System | 0.935899 | 0.029 |
R-HSA-1280218 | Adaptive Immune System | 0.947982 | 0.023 |
R-HSA-9824446 | Viral Infection Pathways | 0.961735 | 0.017 |
R-HSA-9709957 | Sensory Perception | 0.974998 | 0.011 |
R-HSA-372790 | Signaling by GPCR | 0.979113 | 0.009 |
R-HSA-382551 | Transport of small molecules | 0.988120 | 0.005 |
R-HSA-1280215 | Cytokine Signaling in Immune system | 0.992243 | 0.003 |
R-HSA-168256 | Immune System | 0.995538 | 0.002 |
R-HSA-556833 | Metabolism of lipids | 0.998874 | 0.000 |
R-HSA-1430728 | Metabolism | 0.999903 | 0.000 |
Download
kinase | JSD_mean | pearson_surrounding | kinase_max_IC_position | max_position_JSD |
---|---|---|---|---|
PRKD1 |
0.800 | 0.446 | -3 | 0.793 |
PRKD2 |
0.799 | 0.464 | -3 | 0.827 |
RSK3 |
0.788 | 0.443 | -3 | 0.851 |
MAPKAPK2 |
0.788 | 0.434 | -3 | 0.825 |
MAPKAPK3 |
0.787 | 0.434 | -3 | 0.814 |
PRKD3 |
0.786 | 0.463 | -3 | 0.840 |
P90RSK |
0.785 | 0.451 | -3 | 0.847 |
NDR2 |
0.785 | 0.293 | -3 | 0.757 |
SRPK2 |
0.784 | 0.421 | -3 | 0.846 |
RSK2 |
0.784 | 0.428 | -3 | 0.849 |
PKN3 |
0.784 | 0.413 | -3 | 0.796 |
MSK2 |
0.783 | 0.433 | -3 | 0.838 |
SRPK1 |
0.783 | 0.401 | -3 | 0.846 |
PIM3 |
0.783 | 0.383 | -3 | 0.804 |
PIM1 |
0.782 | 0.434 | -3 | 0.834 |
NUAK2 |
0.781 | 0.378 | -3 | 0.818 |
LATS2 |
0.780 | 0.267 | -5 | 0.657 |
NUAK1 |
0.780 | 0.369 | -3 | 0.817 |
CAMK2D |
0.779 | 0.339 | -3 | 0.771 |
MELK |
0.779 | 0.406 | -3 | 0.803 |
AMPKA2 |
0.778 | 0.363 | -3 | 0.801 |
NDR1 |
0.778 | 0.314 | -3 | 0.787 |
AKT2 |
0.778 | 0.467 | -3 | 0.853 |
PKACB |
0.778 | 0.359 | -2 | 0.642 |
CAMK1B |
0.777 | 0.409 | -3 | 0.795 |
CDKL1 |
0.776 | 0.428 | -3 | 0.836 |
PKACG |
0.776 | 0.305 | -2 | 0.702 |
AMPKA1 |
0.776 | 0.328 | -3 | 0.784 |
P70S6KB |
0.776 | 0.394 | -3 | 0.830 |
HIPK4 |
0.775 | 0.286 | 1 | 0.726 |
TSSK1 |
0.774 | 0.306 | -3 | 0.780 |
CAMK1D |
0.774 | 0.463 | -3 | 0.829 |
SGK3 |
0.774 | 0.423 | -3 | 0.826 |
CAMK4 |
0.774 | 0.335 | -3 | 0.781 |
MSK1 |
0.773 | 0.384 | -3 | 0.838 |
RSK4 |
0.773 | 0.407 | -3 | 0.837 |
PKACA |
0.772 | 0.369 | -2 | 0.594 |
SRPK3 |
0.772 | 0.373 | -3 | 0.833 |
CAMK2B |
0.772 | 0.297 | 2 | 0.688 |
AKT1 |
0.772 | 0.430 | -3 | 0.845 |
PRKX |
0.772 | 0.367 | -3 | 0.810 |
PKN2 |
0.772 | 0.314 | -3 | 0.777 |
CAMK1A |
0.772 | 0.474 | -3 | 0.826 |
SIK |
0.772 | 0.334 | -3 | 0.808 |
CAMK2A |
0.771 | 0.322 | 2 | 0.684 |
BRSK1 |
0.771 | 0.311 | -3 | 0.815 |
P70S6K |
0.771 | 0.422 | -3 | 0.843 |
MAPKAPK5 |
0.771 | 0.389 | -3 | 0.836 |
CAMK1G |
0.771 | 0.399 | -3 | 0.836 |
CDKL5 |
0.771 | 0.346 | -3 | 0.843 |
GCN2 |
0.770 | 0.055 | 2 | 0.688 |
PKCD |
0.770 | 0.275 | 2 | 0.698 |
AKT3 |
0.769 | 0.459 | -3 | 0.843 |
PIM2 |
0.769 | 0.420 | -3 | 0.849 |
SKMLCK |
0.769 | 0.292 | -2 | 0.787 |
PHKG1 |
0.769 | 0.304 | -3 | 0.784 |
BRSK2 |
0.769 | 0.257 | -3 | 0.782 |
COT |
0.769 | 0.067 | 2 | 0.732 |
DCAMKL1 |
0.769 | 0.423 | -3 | 0.814 |
SBK |
0.768 | 0.498 | -3 | 0.832 |
MTOR |
0.768 | 0.064 | 1 | 0.798 |
TSSK2 |
0.768 | 0.277 | -5 | 0.775 |
SGK1 |
0.768 | 0.482 | -3 | 0.838 |
ICK |
0.767 | 0.340 | -3 | 0.816 |
RAF1 |
0.767 | 0.144 | 1 | 0.808 |
CAMLCK |
0.767 | 0.329 | -2 | 0.788 |
WNK1 |
0.767 | 0.179 | -2 | 0.785 |
NIM1 |
0.767 | 0.199 | 3 | 0.655 |
PAK1 |
0.767 | 0.248 | -2 | 0.730 |
TBK1 |
0.767 | 0.066 | 1 | 0.782 |
MNK2 |
0.767 | 0.227 | -2 | 0.735 |
PKN1 |
0.766 | 0.428 | -3 | 0.844 |
PAK3 |
0.765 | 0.230 | -2 | 0.734 |
AURC |
0.764 | 0.209 | -2 | 0.633 |
MST4 |
0.764 | 0.156 | 2 | 0.706 |
PKG2 |
0.764 | 0.273 | -2 | 0.637 |
BCKDK |
0.764 | 0.064 | -1 | 0.759 |
NEK6 |
0.764 | 0.059 | -2 | 0.764 |
PRPK |
0.764 | 0.050 | -1 | 0.767 |
ULK2 |
0.764 | 0.027 | 2 | 0.712 |
CLK3 |
0.763 | 0.186 | 1 | 0.683 |
CHK2 |
0.763 | 0.478 | -3 | 0.840 |
DAPK2 |
0.763 | 0.357 | -3 | 0.778 |
NIK |
0.763 | 0.308 | -3 | 0.738 |
PDHK4 |
0.762 | -0.031 | 1 | 0.830 |
MYLK4 |
0.762 | 0.318 | -2 | 0.738 |
DYRK1A |
0.762 | 0.318 | 1 | 0.668 |
PKCA |
0.761 | 0.206 | 2 | 0.641 |
MARK4 |
0.761 | 0.120 | 4 | 0.750 |
CDC7 |
0.761 | 0.028 | 1 | 0.680 |
CHK1 |
0.761 | 0.283 | -3 | 0.762 |
HUNK |
0.761 | 0.067 | 2 | 0.664 |
IKKE |
0.761 | 0.019 | 1 | 0.761 |
PKCB |
0.760 | 0.224 | 2 | 0.635 |
IKKB |
0.760 | 0.029 | -2 | 0.675 |
DYRK2 |
0.760 | 0.214 | 1 | 0.600 |
PDHK1 |
0.760 | -0.013 | 1 | 0.819 |
SNRK |
0.760 | 0.216 | 2 | 0.658 |
QSK |
0.760 | 0.218 | 4 | 0.727 |
ATR |
0.759 | 0.086 | 1 | 0.783 |
AURB |
0.759 | 0.207 | -2 | 0.635 |
AURA |
0.759 | 0.209 | -2 | 0.625 |
WNK3 |
0.759 | 0.071 | 1 | 0.831 |
CLK4 |
0.759 | 0.328 | -3 | 0.844 |
CAMK2G |
0.759 | 0.039 | 2 | 0.720 |
MOS |
0.758 | 0.069 | 1 | 0.752 |
PHKG2 |
0.758 | 0.281 | -3 | 0.790 |
LATS1 |
0.758 | 0.262 | -3 | 0.740 |
MNK1 |
0.758 | 0.207 | -2 | 0.748 |
PKCH |
0.758 | 0.226 | 2 | 0.646 |
PAK6 |
0.757 | 0.176 | -2 | 0.677 |
PKCT |
0.757 | 0.275 | 2 | 0.659 |
NEK7 |
0.757 | -0.004 | -3 | 0.623 |
RIPK1 |
0.757 | 0.155 | 1 | 0.833 |
CLK1 |
0.757 | 0.318 | -3 | 0.841 |
PKCG |
0.756 | 0.186 | 2 | 0.641 |
PAK2 |
0.756 | 0.211 | -2 | 0.726 |
DYRK3 |
0.756 | 0.321 | 1 | 0.642 |
CLK2 |
0.756 | 0.334 | -3 | 0.846 |
QIK |
0.756 | 0.176 | -3 | 0.764 |
PKCZ |
0.755 | 0.177 | 2 | 0.682 |
RIPK3 |
0.755 | 0.054 | 3 | 0.627 |
TGFBR2 |
0.754 | 0.032 | -2 | 0.708 |
DCAMKL2 |
0.754 | 0.305 | -3 | 0.810 |
NLK |
0.753 | 0.044 | 1 | 0.749 |
DSTYK |
0.753 | -0.039 | 2 | 0.748 |
DNAPK |
0.753 | 0.104 | 1 | 0.764 |
ATM |
0.753 | 0.075 | 1 | 0.727 |
MASTL |
0.753 | 0.048 | -2 | 0.754 |
ULK1 |
0.753 | -0.047 | -3 | 0.585 |
NEK9 |
0.752 | 0.014 | 2 | 0.718 |
HIPK2 |
0.752 | 0.212 | 1 | 0.527 |
HIPK1 |
0.751 | 0.255 | 1 | 0.624 |
HIPK3 |
0.751 | 0.251 | 1 | 0.662 |
BMPR2 |
0.750 | -0.083 | -2 | 0.789 |
IRE1 |
0.750 | 0.060 | 1 | 0.808 |
IRE2 |
0.748 | 0.053 | 2 | 0.706 |
SSTK |
0.748 | 0.184 | 4 | 0.746 |
CRIK |
0.748 | 0.435 | -3 | 0.847 |
MRCKB |
0.748 | 0.376 | -3 | 0.824 |
SMMLCK |
0.747 | 0.330 | -3 | 0.813 |
PAK5 |
0.747 | 0.193 | -2 | 0.621 |
IKKA |
0.747 | -0.018 | -2 | 0.652 |
MLK2 |
0.746 | 0.017 | 2 | 0.709 |
MRCKA |
0.746 | 0.353 | -3 | 0.815 |
PKCI |
0.746 | 0.200 | 2 | 0.660 |
ERK5 |
0.745 | -0.038 | 1 | 0.669 |
NEK2 |
0.745 | 0.020 | 2 | 0.698 |
FAM20C |
0.745 | 0.061 | 2 | 0.573 |
MARK2 |
0.745 | 0.103 | 4 | 0.661 |
MLK1 |
0.745 | -0.055 | 2 | 0.701 |
MARK3 |
0.744 | 0.104 | 4 | 0.676 |
PKG1 |
0.744 | 0.295 | -2 | 0.559 |
CHAK2 |
0.744 | -0.028 | -1 | 0.669 |
WNK4 |
0.744 | 0.151 | -2 | 0.775 |
DYRK4 |
0.744 | 0.163 | 1 | 0.517 |
PAK4 |
0.744 | 0.181 | -2 | 0.632 |
PKCE |
0.743 | 0.257 | 2 | 0.629 |
PLK3 |
0.742 | 0.041 | 2 | 0.674 |
MARK1 |
0.742 | 0.118 | 4 | 0.702 |
ANKRD3 |
0.742 | 0.031 | 1 | 0.831 |
ROCK2 |
0.742 | 0.373 | -3 | 0.809 |
PLK4 |
0.742 | 0.059 | 2 | 0.585 |
GRK4 |
0.741 | -0.068 | -2 | 0.780 |
DAPK3 |
0.741 | 0.348 | -3 | 0.819 |
DYRK1B |
0.740 | 0.179 | 1 | 0.561 |
TLK2 |
0.740 | 0.026 | 1 | 0.794 |
GRK5 |
0.740 | -0.120 | -3 | 0.609 |
PLK1 |
0.740 | 0.027 | -2 | 0.738 |
TTBK2 |
0.738 | -0.061 | 2 | 0.613 |
KIS |
0.738 | -0.017 | 1 | 0.594 |
BRAF |
0.737 | 0.118 | -4 | 0.750 |
GRK6 |
0.737 | -0.044 | 1 | 0.686 |
PKR |
0.737 | 0.070 | 1 | 0.819 |
MLK3 |
0.737 | -0.025 | 2 | 0.646 |
HRI |
0.737 | 0.004 | -2 | 0.756 |
DLK |
0.736 | -0.027 | 1 | 0.760 |
ROCK1 |
0.736 | 0.368 | -3 | 0.820 |
VRK2 |
0.735 | 0.040 | 1 | 0.812 |
GRK1 |
0.735 | -0.011 | -2 | 0.755 |
PDK1 |
0.735 | 0.320 | 1 | 0.858 |
MOK |
0.735 | 0.315 | 1 | 0.638 |
YSK4 |
0.735 | -0.011 | 1 | 0.795 |
MAK |
0.735 | 0.292 | -2 | 0.619 |
SMG1 |
0.735 | -0.030 | 1 | 0.765 |
DAPK1 |
0.734 | 0.326 | -3 | 0.829 |
MEK1 |
0.734 | -0.007 | 2 | 0.744 |
TLK1 |
0.734 | 0.025 | -2 | 0.731 |
CDK8 |
0.734 | -0.039 | 1 | 0.556 |
DMPK1 |
0.734 | 0.370 | -3 | 0.826 |
MPSK1 |
0.734 | 0.089 | 1 | 0.796 |
CHAK1 |
0.733 | -0.039 | 2 | 0.687 |
CDK13 |
0.733 | -0.012 | 1 | 0.551 |
CDK7 |
0.732 | -0.009 | 1 | 0.568 |
PERK |
0.732 | 0.000 | -2 | 0.759 |
IRAK4 |
0.731 | 0.043 | 1 | 0.815 |
NEK5 |
0.730 | 0.033 | 1 | 0.837 |
GRK7 |
0.730 | 0.030 | 1 | 0.658 |
PASK |
0.730 | 0.203 | -3 | 0.778 |
JNK2 |
0.730 | 0.029 | 1 | 0.514 |
CDK12 |
0.730 | 0.008 | 1 | 0.529 |
DRAK1 |
0.729 | 0.045 | 1 | 0.693 |
CDK19 |
0.729 | -0.036 | 1 | 0.517 |
MEKK1 |
0.729 | -0.029 | 1 | 0.803 |
TGFBR1 |
0.728 | -0.046 | -2 | 0.684 |
CDK9 |
0.728 | -0.008 | 1 | 0.562 |
TAO3 |
0.728 | 0.090 | 1 | 0.812 |
CDK18 |
0.728 | 0.006 | 1 | 0.499 |
JNK3 |
0.727 | 0.007 | 1 | 0.552 |
NEK8 |
0.727 | 0.080 | 2 | 0.716 |
MEK5 |
0.727 | -0.011 | 2 | 0.730 |
PINK1 |
0.727 | -0.067 | 1 | 0.790 |
CDK5 |
0.726 | -0.002 | 1 | 0.581 |
LKB1 |
0.726 | 0.064 | -3 | 0.622 |
MLK4 |
0.726 | -0.070 | 2 | 0.632 |
ALK4 |
0.726 | -0.087 | -2 | 0.712 |
MST3 |
0.725 | 0.059 | 2 | 0.693 |
NEK4 |
0.725 | 0.058 | 1 | 0.829 |
CDK14 |
0.725 | 0.057 | 1 | 0.551 |
P38A |
0.725 | -0.012 | 1 | 0.599 |
ZAK |
0.723 | -0.044 | 1 | 0.749 |
TAO2 |
0.722 | 0.061 | 2 | 0.731 |
BUB1 |
0.722 | 0.125 | -5 | 0.722 |
RIPK2 |
0.722 | 0.037 | 1 | 0.798 |
CDK10 |
0.722 | 0.077 | 1 | 0.538 |
MEKK3 |
0.722 | -0.056 | 1 | 0.799 |
MEKK2 |
0.722 | -0.023 | 2 | 0.719 |
IRAK1 |
0.720 | -0.061 | -1 | 0.617 |
PBK |
0.720 | 0.120 | 1 | 0.720 |
CK1E |
0.720 | -0.048 | -3 | 0.374 |
NEK1 |
0.719 | 0.082 | 1 | 0.825 |
LOK |
0.718 | 0.081 | -2 | 0.713 |
CAMKK2 |
0.718 | -0.017 | -2 | 0.691 |
CK1G1 |
0.718 | -0.060 | -3 | 0.339 |
NEK11 |
0.718 | -0.016 | 1 | 0.809 |
GSK3B |
0.717 | 0.004 | 4 | 0.419 |
CDK2 |
0.717 | -0.053 | 1 | 0.574 |
PRP4 |
0.717 | -0.039 | -3 | 0.524 |
ALK2 |
0.717 | -0.089 | -2 | 0.712 |
TNIK |
0.717 | 0.075 | 3 | 0.727 |
CDK17 |
0.716 | -0.020 | 1 | 0.438 |
P38G |
0.716 | -0.008 | 1 | 0.426 |
P38B |
0.716 | -0.022 | 1 | 0.501 |
CAMKK1 |
0.716 | -0.074 | -2 | 0.703 |
GCK |
0.716 | 0.069 | 1 | 0.785 |
HPK1 |
0.716 | 0.094 | 1 | 0.784 |
NEK3 |
0.716 | 0.057 | 1 | 0.815 |
KHS1 |
0.716 | 0.120 | 1 | 0.804 |
MEKK6 |
0.715 | 0.048 | 1 | 0.761 |
CDK1 |
0.715 | -0.039 | 1 | 0.494 |
HGK |
0.715 | 0.030 | 3 | 0.719 |
GSK3A |
0.715 | 0.011 | 4 | 0.420 |
ACVR2A |
0.714 | -0.107 | -2 | 0.690 |
BMPR1B |
0.714 | -0.082 | 1 | 0.553 |
MAP3K15 |
0.714 | 0.047 | 1 | 0.784 |
PLK2 |
0.714 | 0.015 | -3 | 0.583 |
VRK1 |
0.713 | 0.101 | 2 | 0.765 |
TTBK1 |
0.713 | -0.103 | 2 | 0.537 |
MINK |
0.713 | 0.040 | 1 | 0.807 |
GRK2 |
0.712 | -0.097 | -2 | 0.647 |
ERK2 |
0.712 | -0.056 | 1 | 0.576 |
LRRK2 |
0.712 | 0.055 | 2 | 0.732 |
ERK1 |
0.711 | -0.045 | 1 | 0.517 |
GAK |
0.711 | 0.027 | 1 | 0.761 |
ACVR2B |
0.711 | -0.122 | -2 | 0.699 |
CDK3 |
0.711 | -0.008 | 1 | 0.447 |
KHS2 |
0.711 | 0.107 | 1 | 0.800 |
CK1D |
0.711 | -0.056 | -3 | 0.323 |
YSK1 |
0.710 | 0.046 | 2 | 0.693 |
CDK4 |
0.710 | 0.027 | 1 | 0.516 |
STK33 |
0.709 | -0.055 | 2 | 0.537 |
TAK1 |
0.709 | 0.047 | 1 | 0.803 |
MST2 |
0.708 | -0.033 | 1 | 0.786 |
MEK2 |
0.708 | -0.031 | 2 | 0.736 |
CK1A2 |
0.706 | -0.070 | -3 | 0.343 |
ERK7 |
0.706 | -0.034 | 2 | 0.435 |
CDK16 |
0.705 | -0.024 | 1 | 0.459 |
SLK |
0.705 | -0.013 | -2 | 0.648 |
MST1 |
0.703 | -0.034 | 1 | 0.798 |
TAO1 |
0.702 | 0.063 | 1 | 0.807 |
CDK6 |
0.702 | -0.021 | 1 | 0.545 |
P38D |
0.702 | -0.036 | 1 | 0.479 |
EEF2K |
0.701 | -0.050 | 3 | 0.699 |
JNK1 |
0.701 | -0.027 | 1 | 0.485 |
HASPIN |
0.701 | 0.040 | -1 | 0.510 |
GRK3 |
0.701 | -0.087 | -2 | 0.612 |
CK2A2 |
0.700 | -0.012 | 1 | 0.528 |
MYO3B |
0.699 | 0.038 | 2 | 0.706 |
BMPR1A |
0.696 | -0.118 | 1 | 0.535 |
OSR1 |
0.693 | -0.015 | 2 | 0.694 |
LIMK2_TYR |
0.692 | 0.170 | -3 | 0.690 |
BIKE |
0.692 | 0.037 | 1 | 0.656 |
MYO3A |
0.690 | -0.006 | 1 | 0.812 |
ASK1 |
0.690 | -0.011 | 1 | 0.770 |
PDHK3_TYR |
0.690 | 0.078 | 4 | 0.825 |
TESK1_TYR |
0.688 | 0.083 | 3 | 0.748 |
CK2A1 |
0.688 | -0.030 | 1 | 0.506 |
PKMYT1_TYR |
0.688 | 0.075 | 3 | 0.721 |
TTK |
0.687 | -0.016 | -2 | 0.750 |
MAP2K4_TYR |
0.686 | 0.081 | -1 | 0.764 |
NEK10_TYR |
0.685 | 0.142 | 1 | 0.782 |
PINK1_TYR |
0.684 | 0.100 | 1 | 0.811 |
MAP2K7_TYR |
0.684 | -0.000 | 2 | 0.754 |
LIMK1_TYR |
0.683 | 0.060 | 2 | 0.755 |
RET |
0.683 | 0.079 | 1 | 0.799 |
MAP2K6_TYR |
0.682 | -0.000 | -1 | 0.770 |
ALPHAK3 |
0.682 | -0.040 | -1 | 0.683 |
AAK1 |
0.682 | 0.066 | 1 | 0.563 |
YANK3 |
0.682 | -0.041 | 2 | 0.319 |
PDHK4_TYR |
0.681 | -0.029 | 2 | 0.762 |
DDR1 |
0.679 | 0.072 | 4 | 0.778 |
STLK3 |
0.679 | -0.058 | 1 | 0.765 |
TNNI3K_TYR |
0.679 | 0.070 | 1 | 0.757 |
TYK2 |
0.677 | -0.017 | 1 | 0.795 |
TNK1 |
0.676 | 0.086 | 3 | 0.643 |
MST1R |
0.675 | 0.005 | 3 | 0.652 |
JAK1 |
0.674 | 0.062 | 1 | 0.787 |
ROS1 |
0.674 | 0.009 | 3 | 0.621 |
CK1A |
0.674 | -0.088 | -3 | 0.245 |
PDHK1_TYR |
0.673 | -0.119 | -1 | 0.747 |
JAK3 |
0.673 | 0.004 | 1 | 0.793 |
BMPR2_TYR |
0.672 | -0.089 | -1 | 0.713 |
JAK2 |
0.671 | -0.055 | 1 | 0.776 |
CSF1R |
0.670 | -0.026 | 3 | 0.637 |
TYRO3 |
0.670 | -0.045 | 3 | 0.644 |
ABL2 |
0.669 | 0.004 | -1 | 0.720 |
FGR |
0.668 | -0.044 | 1 | 0.731 |
EPHA6 |
0.668 | -0.036 | -1 | 0.697 |
INSRR |
0.667 | -0.016 | 3 | 0.583 |
PDGFRB |
0.666 | -0.042 | 3 | 0.641 |
WEE1_TYR |
0.665 | 0.024 | -1 | 0.664 |
PDGFRA |
0.665 | -0.039 | 3 | 0.643 |
ABL1 |
0.665 | -0.020 | -1 | 0.708 |
TNK2 |
0.664 | -0.026 | 3 | 0.580 |
EPHB4 |
0.664 | -0.060 | -1 | 0.716 |
FGFR2 |
0.664 | -0.050 | 3 | 0.627 |
FLT3 |
0.664 | -0.031 | 3 | 0.633 |
FGFR1 |
0.664 | -0.049 | 3 | 0.598 |
KDR |
0.663 | -0.029 | 3 | 0.593 |
YES1 |
0.661 | -0.073 | -1 | 0.688 |
DDR2 |
0.661 | 0.069 | 3 | 0.554 |
AXL |
0.659 | -0.044 | 3 | 0.612 |
PTK6 |
0.659 | -0.076 | -1 | 0.653 |
NTRK1 |
0.658 | -0.062 | -1 | 0.760 |
CK1G3 |
0.658 | -0.098 | -3 | 0.208 |
KIT |
0.658 | -0.091 | 3 | 0.635 |
LTK |
0.657 | -0.040 | 3 | 0.580 |
NTRK2 |
0.656 | -0.075 | 3 | 0.583 |
ALK |
0.656 | -0.056 | 3 | 0.544 |
FLT4 |
0.656 | -0.061 | 3 | 0.611 |
INSR |
0.655 | -0.047 | 3 | 0.576 |
FER |
0.655 | -0.163 | 1 | 0.690 |
EPHB3 |
0.653 | -0.105 | -1 | 0.713 |
TEK |
0.653 | -0.137 | 3 | 0.572 |
MERTK |
0.653 | -0.086 | 3 | 0.618 |
HCK |
0.653 | -0.136 | -1 | 0.652 |
FGFR3 |
0.652 | -0.082 | 3 | 0.594 |
NTRK3 |
0.652 | -0.052 | -1 | 0.758 |
LCK |
0.651 | -0.099 | -1 | 0.646 |
MET |
0.651 | -0.092 | 3 | 0.614 |
BTK |
0.651 | -0.149 | -1 | 0.620 |
EPHB2 |
0.650 | -0.112 | -1 | 0.690 |
FLT1 |
0.650 | -0.103 | -1 | 0.687 |
EPHB1 |
0.650 | -0.152 | 1 | 0.677 |
EPHA4 |
0.649 | -0.135 | 2 | 0.656 |
EPHA1 |
0.649 | -0.072 | 3 | 0.588 |
ERBB2 |
0.649 | -0.126 | 1 | 0.698 |
TXK |
0.648 | -0.100 | 1 | 0.627 |
EPHA3 |
0.648 | -0.116 | 2 | 0.645 |
SRMS |
0.647 | -0.168 | 1 | 0.665 |
MATK |
0.646 | -0.061 | -1 | 0.689 |
ITK |
0.644 | -0.160 | -1 | 0.645 |
BMX |
0.644 | -0.090 | -1 | 0.611 |
BLK |
0.643 | -0.104 | -1 | 0.649 |
CSK |
0.643 | -0.081 | 2 | 0.663 |
MUSK |
0.642 | -0.062 | 1 | 0.625 |
EPHA7 |
0.641 | -0.130 | 2 | 0.659 |
TEC |
0.641 | -0.158 | -1 | 0.596 |
YANK2 |
0.640 | -0.103 | 2 | 0.345 |
FGFR4 |
0.640 | -0.078 | -1 | 0.692 |
EPHA5 |
0.639 | -0.106 | 2 | 0.658 |
IGF1R |
0.639 | -0.074 | 3 | 0.517 |
FYN |
0.639 | -0.105 | -1 | 0.613 |
EGFR |
0.638 | -0.091 | 1 | 0.587 |
FRK |
0.637 | -0.160 | -1 | 0.656 |
LYN |
0.635 | -0.160 | 3 | 0.585 |
PTK2B |
0.635 | -0.128 | -1 | 0.652 |
SRC |
0.632 | -0.131 | -1 | 0.634 |
EPHA8 |
0.632 | -0.139 | -1 | 0.676 |
CK1G2 |
0.624 | -0.120 | -3 | 0.277 |
SYK |
0.620 | -0.127 | -1 | 0.628 |
EPHA2 |
0.620 | -0.150 | -1 | 0.644 |
PTK2 |
0.618 | -0.140 | -1 | 0.568 |
ERBB4 |
0.616 | -0.129 | 1 | 0.527 |
ZAP70 |
0.610 | -0.067 | -1 | 0.615 |
FES |
0.607 | -0.170 | -1 | 0.606 |